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Chapter 1 
Literature review 
 
1.1. Introduction 
 
Medicinal plants are part of indigenous people‟s cultural heritage, thus since ancient 
times treatment of various diseases using medicinal plants has been part of human 
culture. The value of medicinal plants to mankind has been very well proven. It is 
estimated that 70% to 80% of people worldwide rely mainly on traditional health care 
systems, especially on herbal medicines (Stanley and Luz, 2003). 
 
In many societies the medicinal properties of plants were discovered mostly through 
trial and error, but use was also influenced by the belief systems of the people 
involved and often became entangled with religious and mythical practices (Mathias 
et al., 1996). Besides that, medicinal plants are proving to be rich resources of 
constituents that can be used in drug development and synthesis. 
 
Medicinal plants have been a source of a wide variety of biologically active 
compounds for many centuries and have been used extensively as crude material or 
as pure compounds for treating various disease conditions. Between 1% and 10% of 
plants out of an estimated 250 000 to 500 000 species of plants on earth are used by 
humans (Boris, 1996). 
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Plants used for medicinal purposes contribute significantly to the development of 
major medical drugs that are used today. Most common medicines have compounds 
extracted from plants as their primary active ingredients and many have provided 
blueprints for synthetic or partially synthesized drugs (Simpson and Ogorzaly, 2001). 
 
There has been a major resurgence of interest in traditionally used medicinal plants, 
with a number of international and local initiatives actively exploring the botanical 
resources of southern Africa with the intention to screen indigenous plants for 
pharmacologically active compounds (Gurib-Fakim et al., 2010; Rybicki et al., 2012). 
 
South Africa is considered a “hot spot” for biodiversity and more than 22 000 plant 
species occur within its boundaries.  This represents 10% of the world‟s species, 
although the land surface of South Africa is less than 1% of the earth‟s surface 
(Coetzee et al., 1999). 
 
Plants have also been used by man for various purposes, among others as arrow 
and dart poisons for hunting, poisons for murder, hallucinogens used for ritualistic 
purposes, stimulants for endurance and hunger suppression, as well as medicine 
(Duke et al., 2008; Cragg and Newman, 2005).   
 
A derivative of the polyhydroxy diterpenoid ingenol isolated from the sap of 
Euphorbia peplus (known as “petty spurge” in England or “radium weed” in 
Australia), which is a potential chemotherapeutic agent for skin cancer, is currently 
under clinical development by Peplin Biotech for the topical treatment of certain skin 
cancers (Kedei et al., 2004; Ogbourne et al., 2004).  Combretastatin A-4 phosphate, 
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a stilbene derivative from the South African bush willow, Combretum caffrum, acts as 
an anti-angiogenic agent causing vascular shutdowns in tumors (Newman et al., 
2005; Holwell et al., 2002). 
 
Further reliance on plants for drug development is demonstrated by the use of 
galantamine hydrobromide, an alkaloid obtained from the plant Galanthus nivalis 
used traditionally in Turkey and Bulgaria for the treatment of Alzheimer‟s disease 
(Howes et al., 2003; Heinrich and Teoh, 2004).  
 
The plant chemicals used for the above-mentioned purposes are secondary 
metabolites, which are derived biosynthetically from plant primary metabolites (e.g. 
carbohydrates, amino acids and lipids).  Secondary metabolites are organic 
compounds that are exclusively produced by plants and that are not directly involved 
in the normal growth, development and reproduction of a plant (Firn and Jones, 
2003).  Yet, they have many functions that are important for the plant‟s long-term 
health and appearance. 
 
Plants, being stationary, have to cope with a number of challenges, including 
engineering their own pollination and seed dispersal, local variation in the supply of 
the simple nutrients that they require to synthesize their food and the coexistence of 
herbivores and pathogens in their immediate environment.  Plants have therefore 
evolved secondary biochemical pathways that allow them to synthesize a spectrum 
of organic molecules, often in response to specific environmental stimuli, such as 
herbivore-induced damage, pathogen attacks, or nutrient deprivation (Reymond et 
al., 2000; Hermsmeier et al., 2001). 
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The biosynthesis of secondary metabolites is derived from the fundamental 
processes of photosynthesis, glycolysis and the Krebs cycle to afford biosynthetic 
intermediates which, ultimately, result in the formation of secondary metabolites also 
known as natural products (Dewick, 2002).  
 
It is hypothesized that secondary metabolism utilizes amino acids and the acetate 
and shikimate pathways to produce “shunt metabolites” (intermediates) that have 
adopted an alternate biosynthetic route, leading to the biosynthesis of secondary 
metabolites (Sarker et al., 2006).  
 
Modifications in the biosynthetic pathways that produce secondary metabolites are 
probably due to natural causes (e.g. viruses or environmental changes) or unnatural 
causes (e.g. chemical or radiation processes) in an effort to adapt or provide 
longevity for the plant (Sarker et al., 2006). Plants‟ secondary metabolites can be 
classified into several groups according to their chemical classes, such alkaloids, 
terpenoids and phenolics (Harbone, 1984; Wink, 2003). 
 
1.2. Classification of plants’ secondary metabolites 
 
The palette of secondary metabolites can be divided into a number of distinct groups 
on the basis of their chemical structure and synthetic pathways.  These groups can, 
in turn, be broadly differentiated in terms of the nature of their ecological roles and 
therefore their ultimate effects and comparative toxicity in the consuming animal 
(Kennedy and Whightman, 2011).  The three main groups of secondary metabolites 
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in plants that are of interest in this study are alkaloids, phenolic compounds and 
terpenoids (Firn and Jones, 2003; Wink, 2003). 
 
1.2.1. Alkaloids 
 
Alkaloids are complex N-containing heterocyclic organic compounds and are among 
the most important plant materials for the development and production of drugs 
(Facchini, 2001).  Although no single classification exists, Kennedy and Whightman 
(2011) argued that alkaloids are often distinguished on the basis of a structural 
similarity (e.g. indole alkaloids) or a common precursor (e.g. benzylisoquinoline, 
tropane, pyrrolizidine, or purine alkaloids). 
 
Figure 1.1. Alkaloids (taken from Kennedy and Whightman, 2011). 
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The recorded use of alkaloids for medicinal purposes stretches back some 5 000 
years (Goldman, 2001) and this class of molecules has contributed to  the majority of 
poisons, neurotoxins, traditional psychedelics (e.g. atropine, scopolamine and 
hyoscyamine, from the plant Atropa belladonna) and social drugs consumed by 
humans, e.g. nicotine, caffeine, methamphetamine (ephedrine), cocaine and opiates,  
(Zenk and Juenger, 2007). 
 
1.2.2. Phenolic compounds 
 
Phenolic compounds (Harborne and Williams, 2000) are based on phenol (an 
oxygen linked to a fully saturated C6 ring), the simplest member of this class of plant 
substances. Phenolic compounds include, among others, flavonoids and tannins 
(Harborne and Williams, 2000).  Phenols are the compounds containing a hydroxyl 
group (—OH) directly attached to an aromatic ring.  
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Figure 1.2. Phenols (Aggarwal and  Shishodia,  2006;  Dewick, 2002) 
 
Phenolic compounds, in particular flavonoids, are generally involved in the protection 
of plants from attack by microbes and insects (Cushnie and Lamb, 2005; Friedman, 
2007).  
 
Special classes of plant phenolics are the tannins, characteristically astringent, bitter 
plant polyphenols that are toxic to herbivores owing to their capacity to either bind 
and precipitate, or shrink proteins and other macromolecules (Cushnie and Lamb, 
2005).  Some phenols are used as chemopreventive agents, e.g.  resveratrol (3, 5, 
4-trihydroxystilbene) is an oligomeric polyphenol found as dimer, trimer and tetramer.  
This molecule is implicated in the prevention of cancer and cardiovascular diseases 
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in vasoprotection and neuroprotection (Ates et al., 2007; Delmas et al., 2006; Vitrac 
et al., 2004).  
 
Acetylsalicylic acid (aspirin) a time-honored analgesic and antipyretic drug, was 
derived from salicylic acid, which occurs in willow trees.  Some other important 
salicylic acid derivatives are methyl salicylate, a common ingredient of liniments 
(Dewick, 2002).  Eugenols extracted from cloves are used as an anesthetic and 
antiseptic in pharmaceutical and dental preparations (Daniel et al., 2009).  
 
1.2.3. Terpenoids 
 
Terpenoids are dimers or combinations of isoprene, a common organic compound 
that is highly volatile because of its low boiling point (Zwenger and Basu, 2008).  
This class of molecules is diverse and consists of groups of more than 30 000 lipid-
soluble compounds.  Their structure includes one or more five-carbon isoprene units, 
which are ubiquitously synthesized by all organisms through two potential pathways, 
the mevalonate and  deoxy-d-xylulose pathways (Rohmer, 1999).  
 
The general chemical structure of terpens is C10H16, and they occur as diterpenes, 
triterpenes, and tetraterpenes (C20, C30, and C40), as well as hemiterpenes (C5) and 
sesquiterpenes (C15) (Arif et al., 2011). 
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Figure 1.3. Basic building unit and various classes of terpenes (taken from Hao et 
al., 2013). 
 
Geraniol, an acyclic dietary monoterpene, represents the only monoterpene that has 
been studied in vitro against liver cancer cells.  Geraniol was shown to inhibit the 
growth of HepG2 human hepatic carcinoma cells by decreasing 3-
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hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase, the major rate-limiting 
enzyme in cholesterol biosynthesis in mammals (Polo and Bravo, 2006). 
 
Ardisiacrispin (A+B), a triterpenoid saponin mixture in the fixed proportion 2:1 of 
ardisiacrispin A and ardisiacrispin B, is derived from Ardisia crenata. This mixture 
exerted cytotoxic activity against Bel-7402 liver cancer cells through pro-apoptotic, 
anti-proliferative and microtubule disruptive activities (Li et al., 2008). 
 
1.3. Biosynthetic pathways 
 
The synthesis of different classes of secondary metabolites from primary metabolites 
is presented in schematic form in Fig. 1.4.   
 
Figure 1.4. Principal biosynthetic pathways leading to synthesis of secondary 
metabolites. Adapted from Ramawat et al. (2009).  
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Secondary metabolites are predominantly synthesized via two principal biosynthetic 
pathways.  The first one, the shikimic acid pathway, produces a pool of aromatic 
amino acids, which in turn are converted into diverse compounds such as phenolics 
(lignins, tannins, quinones) and alkaloids (Mustafa and Verpoorte, 2007).  The 
second one is the acetyl-CoenzymeA mevalonic acid pathway, which produces a 
vast array of terpenoids (Eisenreich et al., 2004). 
 
1.4. Drug development 
 
Though enormous progress has been made in medicinal chemistry, the development 
of a novel drug has become more and more difficult.  The reasons are manifold, 
including the fact that good drugs are available for major diseases, and developing a 
better drug that is active on the same target without being more expensive becomes 
increasingly difficult in view of the sophistication in industrial production methods 
(Wess et al., 2001). 
 
Despite the recent interest in molecular modeling, combinatorial chemistry, and other 
synthetic chemistry techniques by pharmaceutical companies and funding 
organizations, natural products, particularly medicinal plants, remain an important 
source of new drugs, new drug leads and new chemical entities (Newman et al., 
2000; Newman et al 2003; Butler, 2004). 
 
Interestingly, of the 877 novel medicines that were developed in the period 1981-
2002, 6% were natural products, 27% were derivatives of natural products and 16% 
were synthetics developed on the model of a natural product (Newman et al., 2003).  
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This demonstrates that nature is an important source for developing novel leads for 
medicines.  Even when new chemical structures are not found during drug discovery 
from medicinal plants, known compounds with new biological activity can provide 
important drug leads.  Since the sequencing of the human genome, thousands of 
new molecular targets have been identified as important in various diseases (Kramer 
and Cohen, 2004).  The history of drug discovery and even drug chemistry that is 
inexorably bound to the plant kingdom confirms that the process of deriving drugs 
from plant sources is certainly not a new phenomenon. 
 
Several known compounds isolated from traditionally used medicinal plants have 
already been shown to act on newly validated molecular targets, as exemplified by 
indirubin, which selectively inhibits cyclin-dependent kinases (Hoessel et al., 1999; 
Eisenbrand et al., 2004) and kamebakaurin, which has been shown to inhibit NF- kB 
(Hwang et al., 2001; Lee et al., 2002). 
 
1.4.1. Anti-microbial activity 
 
It is estimated that plant materials are present in or have provided the models for 
50% of Western drugs developed today (Robbers et al., 1996).  Many commercial 
drugs used in modern medicine today were initially used in crude form in traditional 
or folk healing practices, or for other purposes that confirmed their potential useful 
biological activity.  Avancini et al. (2000) demonstrated the antimicrobial actions of 
“carqueja” (Baccharis trimera Less.) extracts on Gram-positive (Staphylococcus 
aureus and Streptococcus uberis) and Gram-negative (Salmonella gallinarum and 
Escherichia coli) bacterial strains.  
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High antimicrobial activity of Thymus, Origanum and Eugenia caryophillus species 
has been attributed to their phenolic components such as thymol and carvacrol 
(Lambert et al., 2001; Hazzit et al., 2009).  Similarly, the antimicrobial activity of 
Cinnamomum zeylanicum has been related to its cinnamaldehyde content (Juliani et 
al., 2009). 
 
1.4.2. Anti-cancer activity 
 
The search for anti-cancer agents from plant sources started in the 1950s with the 
discovery and development of the vinca alkaloids, vinblastine and vincristine, and the 
isolation of the cytotoxic podophyllotoxins (Cragg and Newman, 2005).  The first 
agents to advance into clinical use were the so-called vinca alkaloids, vinblastine 
and vincristine, isolated from the Madagascar periwinkle, Catharanthusroseus 
(Gueritte and Fahy, 2005).  These agents are primarily used in combination with 
other cancer chemotherapeutic drugs for the treatment of a variety of cancers, 
including leukemia, lymphoma, advanced testicular cancer, breast and lung cancer 
and Kaposi‟s sarcoma. 
 
Combretastatins were isolated from an indigenous South African plant, Combretum 
caffrum (Pinney et al., 2005).  These molecules have served as a model for the 
treatment of tumors and as a result many synthetic analogues of Combretastatin-4 
have been created in order to improve its cytoxicity and inhibition of tubulin 
polymerization (Nam, 2003; Ohsumi et al., 1998).  That has provided an impressive 
display of the power of a relatively simple natural product structure that can be 
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altered to produce superior products through medicinal and combinatorial chemistry 
(Li and Sham, 2002).  
 
1.4.3. Anti-diabetic activity 
 
The aqueous leaf extract of A. squamosa has been reported to ameliorate 
hyperthyroidism (Sunanda and Anand, 2003), which is considered a causative factor 
for diabetes mellitus.  However, the mechanism involved in the extract‟s inhibition of 
hyperthyroidism is not known.  More than 1000 plant species are being used for the 
treatment of Type II diabetes mellitus worldwide (Trojan-Rodrigues et al., 2011).  
Similar to the A. squamosa extract, very little is known about the mechanism of 
action of these anti-diabetic plants, thus limiting their use in standard diabetes care.  
Many plants have shown anti-diabetic action through the release of insulin and some 
extra pancreatic mechanisms (Jung et al., 2006). However, more investigations must 
be carried out to evaluate the exact mechanism of action of medicinal plants with 
anti-diabetic and insulin-mimetic activity (Patel et al., 2012).  
 
Phytoconstituents such as alkaloids inhibit alpha-glucosidase and decrease glucose 
transport through the intestinal epithelium and imidazoline compounds stimulate 
insulin secretion in a glucose-dependent manner (Patel et al., 2012).  This shows 
most researchers‟ preference for pure or semi-pure molecules in evaluating 
mechanisms of action.  This leads to poor validation of the health benefits and 
biosafety of many plants that are traditionally used. 
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1.4.4. Anti-oxidant activity 
 
Antioxidant-based drugs/formulations for the prevention and treatment of complex 
diseases such as atherosclerosis, stroke, diabetes, Alzheimer‟s disease and cancer 
have emerged in the last three decades (Devasagayam et al., 2004).  This coincides 
with the upsurge of interest in the therapeutic potentials of plants as antioxidants in 
reducing free radical induced tissue injury.  Although many synthetic anti-oxidants, 
such as butylated hydroxyanisole (BHA) and butylated hydroxytoluene   
(BHT) are commercially available, their toxicity is a growing concern.  Both 
carcinogenic and anticarcinogenic properties have been reported for the synthetic 
antioxidants BHA and BHT (Botterweek et al., 2000). 
 
In dealing with the toxicity of synthetic anti-oxidants, a worldwide trend towards the 
use of natural phytochemicals present in berries, tea, herbs, oilseeds, beans, fruit 
and vegetables has increased (Lee and Shibamoto, 2000; Wang and Jiao, 2000).   
 
Natural antioxidants, especially phenolics and flavonoids from tea, wine, vegetables 
and spices, are already exploited commercially either as antioxidant additives or 
nutritional supplements (Schuler, 1990; Chu et al., 2000).   
 
Many other plant species have also been investigated in the search for novel 
antioxidants, but there is generally still a demand to find more information concerning 
the antioxidant potential of plant species, as they are safe and bioactive.   
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1.5. Asparagus laricinus 
 
Knowledge about the medicinal value of many plants that form part of the rich 
biodiversity in South Africa is largely contained in the oral traditions of various ethnic 
groups that constitute the indigenous people of South Africa (van der Merwe et al., 
2001).  Loss of indigenous culture, in favor of western European-derived culture, is 
an accelerating process among indigenous people around the world (Prance, 1994).  
Consequently, the traditional knowledge that forms the basis of the use of medicinal 
plants is in danger of being lost and warrants rigorous scientific investigation.   
 
The current study was prompted by case reports describing unexpected 
improvement in patients who had been terminally ill with advanced prostate cancer. 
Clinicians had no explanation for the improvement.  When questioned by the 
clinicians, these patients reported that they had been treated with an extract from the 
root of a medicinal plant.  This plant material was offered to researchers for initial 
analysis for anti-cancer activity.  After characterization by a botanist, the plant was 
found to be Asparagus laricinus (A. laricinus), belonging to a monogeneric family 
called Asparagaceae, under the subfamily Asparagoidiae (Brummit, 1992).  This 
plant is commonly known as lesitwane among the Batswana clans in South Africa.  
Traditionally tubers of this plant are used to treat sores, redwater and uterine 
infection. However, informants in the study attributed the action of this medicinal 
plant to a physical mechanism that they could not explain owing to lack of knowledge 
(van der Merwe et al., 2001).  These claims, the efficacy of the use of the A. laricinus 
plant and its therapeutic potential have not been investigated scientifically. 
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Objectives of the study: To prepare a crude plant extract of A. laricinus, broadly 
establish the bioactivity and describe the phytochemical properties of A. laricinus 
water extract.  
Specific aims: 
 To conduct in vitro anti-cancer screening of A. laricinus extract  
 To evaluate the mutagenic and cytotoxic effect of the plant 
 To evaluate the radical scavenger and anti-oxidative stress 
activities  
 To evaluate the anti-microbial activity of A. laricinus aqueous 
extract  
 To examine the chemical composition of both aqueous and 
methanol extracts 
18 
 
1.6. References 
 
Aggarwal B.B., and Shishodia S.  2006.  Molecular targets of dietary agents for 
prevention and therapy of cancer.  Biochemical Pharmacology, (71): 1397–1421. 
 
Arif T., Mandal T.K., and Dabur R.  2011.  Natural products: Anti-fungal agents 
derived from plants.  Opportunity, Challenge and Scope of Natural Products in 
Medicinal Chemistry, 283–311. ISBN: 978-81-308-0448-4. 
 
Ates O., Cayli S, Altinoz E., Gurses I., Yucel N., Sener M., Kocak A., and 
Yologlu S.  2007.  Neuroprotection by resveratrol against traumatic brain injury in 
rats.  Molecular Cell Biochemistry, (294): 137–144. 
 
Avancini C.A.M., Wiest J.M., and Mundstock E.  2000.  Bacteriostatic and 
bactericidal activity of the Baccharis trimera (Less.) D.C. - Compositae decocto, as 
disinfectant or antiseptic.  Brazilian Journal of Veterinary and Animal Science, 3(52): 
230–234. 
 
Borris R.P.  1996.  Natural products research: Perspectives from a major 
pharmaceutical company.  Ethnopharmacoogy, (51): 29. 
 
Botterweek A.A., Verhagen H., Goldbohm R.A., Kleinjans J., and van den 
Brandt P.A.  2000.  Intake of butylated hydroxyanisole and butylated hydroxytoluene 
and stomach cancer risk: Results from the analyses in the Nederland cohort study. 
Food and Chemical Toxicology, 38 (7): 599–605.  
19 
 
Brummitt R.K.  1992.  Vascular plant families and genera.  Royal Botanical 
Gardens, Kew, p 804. 
 
Butler M.S.  2004.  The role of natural product chemistry in drug discovery. Journal 
of Natural Products, 67 (12): 2141–2153. 
 
Chu, Y.H., Chang, C.L., and Hsu, H.F.  2000.  Flavonoid content of several 
vegetables and their antioxidant activity. Journal of the Science of Food and 
Agriculture, (80): 561–566. 
 
Coetzee C., Jefthas E., and Reinten E.  1999.  Indigenous plant genetic resources 
of South Africa.  J. Janick (ed.), ASHS Press, Alexandria, VA.  
 
Cragg G.M. and Newman D.J.  2005.  Biodiversity: A continuing source of novel 
drug leads. Pure Applied Chemistry, (77): 7–24. 
 
Cushnie T.P., and Lamb A.J.  2005.  Antimicrobial activity of flavonoids.  
International Journal of Antimicrobial  Agents, (26): 343–356. 
 
Daniel A.N., Sartoretto S.M., Schmidt G., Caparroz-Assef S.M., Bersani-Amado 
C.A., and Cuman R.K.N.  2009.  Anti-inflammatory and antinociceptive activities of 
eugenol essential oil in experimental animal models. Revista Brasileira de 
Farmacognosia, (19): 212- 217. 
 
20 
 
Delmas D., Jannin B., and Latruffe N.  2006.  Resveratrol: Preventing properties 
against vascular alterations and ageing. Molecular  Nutrition and  Food Research, 49 
(5): 377-395.  
 
Devasagayam T.P., Tilak J.C., Boloor K.K., Sane K.S., Ghaskadbi S.S., and Lele 
R.D.  2004.  Free radicals and antioxidants in human health: Current status and 
future prospects.  The Journal of Association of Physicians of India, (52): 794-804. 
 
Dewick P.M.  2002.  Medicinal Natural Products: A Biosynthentic Approach, 2nd ed.; 
John Wiley and Son: West Sussex, UK, p. 520. 
 
Duke J.A., Duke P.A.K., and du Cellier J.L.  2008.  Duke's Handbook of Medicinal 
Plants of the Bible; CRC Press Taylor and Francis Group: Boca Raton, FL, USA, p. 
552. 
 
Eisenbrand G., Hippe F., Jakobs S., and Muehlbeyer S.  2004.  Molecular 
mechanisms of indirubin and its derivatives: Novel anticancer molecules with their 
origin in traditional Chinese phytomedicine.  Journal of Cancer Research and Clinical 
Oncology, 130(11): 627–635. 
 
Facchini P.J.  2001.  Alkaloid biosynthesis in plants: Biochemistry, cell biology, 
molecular regulation, and metabolic engineering applications.  Annual  Review of  
Plant Physiology and  Plant Molecular  Biology, (52): 29–66. 
 
21 
 
Firn R.D., and Jones CG.  2003.  Natural products - a simple model to explain 
chemical diversity.  Natural  Products  Reports, (20): 382-391. 
 
Friedman M.  2007.  Overview of antibacterial, antitoxin, antiviral, and antifungal 
activities of tea flavonoids and teas.  Molecular   Nutrition and Food Research, (51): 
116-134. 
 
Goldman P.  2001.  Herbal medicines today and the roots of modern pharmacology.  
Annals of Internal Medicine, (135): 594–600. 
 
Gueritte F., and Fahy J.  2005.  The vinca alkaloids. In: Cragg, G.M., Kingston, 
D.G.I., Newman D.J. (Eds.), Anticancer Agents from Natural Products. Boca Raton, 
FL: Brunner-Routledge Psychology Press, Taylor & Francis Group, pp. 123–136. 
 
Gurib-Fakim A,.  Brendler T., Philips L.D., and Eloff J.N.  2010.  Green Gold 
Success Stories Using Southern African Medicinal Plant Species, AAMPS Publishing 
 
Hao D., Gu X., Xiao P., Liang Z., Xu L., and Peng Y.  2013.  Research progress in 
the phytochemistry and biology of Ilex pharmaceutical resources.  Acta 
Pharmaceutica Sinica B, 3(1): 8–19. 
 
Harborne J.B.  1984.  Phytochemical Methods; A guide to modern techniques of 
plant Analysis.2nd Edition, London New York. 
 
22 
 
Harborne J.B, and Williams C.A.  2000.  Advances in flavonoid research since 
1992. Phytochemistry, (55): 481–504. 
 
Hazzit M., Baaliouamer A., Verissimo A.R., Faleiro M.L., and Miguel M.G.  2009.  
Chemical composition and biological activities of Algerian Thymus oils. Food 
Chemisty, (116): 714–721. 
 
Heinrich M., and Teoh H.L.  2004.  Galanthamine from snowdrop-the development 
of a modern drug against Alzheimer's disease from local Caucasian knowledge. 
Journal of Ethnopharmacology, (92): 147–162. 
 
Hermsmeier D., Schittko U., and Baldwin I.T.  2001.  Molecular interactions 
between the specialist herbivore Manduca sexta (Lepidoptera, Sphingidae) and its 
natural host Nicotiana attenuata. I. Large-scale changes in the accumulation of 
growth- and defense-related plant mRNAs.  Plant Physiology, (125): 683–700. 
 
Hoessel R., Leclerc S., Endicott J.A., Nobel M.E., Lawrie A., Tunnah P., Leost 
M., Damiens E., Marie D., Marko D., Niederberger E., Tang W., Eisenbrand G., 
and Meijer L.  1999.  Indirubin, the active constituent of a Chinese antileukaemia 
medicine, inhibits cyclin-dependent kinases.  Nature Cell Biology, 1 (1): 60–67. 
 
Holwell S.E., Cooper P.A., Grosios J.W., Lippert J.W., III; Pettit, G.R.; Snyder, 
S.D.; Bibby, M.C.  2002.  Combretastatin A-1 phosphate, a novel tubulin-binding 
agent with in-vivo anti-vascular effects in experimental tumors.  Anticancer 
Research, (22): 707–712. 
23 
 
 
Howes M.-J.R.; Perry N.S.L, and Houghton P.J.  2003.  Plants with traditional 
uses and activities, relevant to the management of Alzheimer's disease and other 
cognitive disorders.  Phytotherapy  Research, (17): 1–18. 
 
Hwang B.Y., Lee J.H., Koo T.H., Kim H.S., Hong Y.S., Ro J.S., Lee K.S., and Lee 
J.J.  2001.  Kaurane diterpenes from Isodon japonicus inhibit nitric oxide and 
prostaglandin E2 production and NF-kB activation in LPS stimulated macrophage 
RAW 264.7 cells.  Planta Medica, 67 (5): 406–410. 
 
Juliani H.R., Koroch A.R., and Simon, J.E.  2009.  Chemical diversity of essential 
oils of Ocimum species and their associated antioxidant and antimicrobial activity. In 
Chemat, F., Varshney, V.K., and Allaf, K. (Eds.) Essential Oils and Aromas: Green 
Extractions and Applications, Dehradun, India:.Har Krishan Bhalla & Sons:  
 
Jung M., Park M., Lee H.C., Kang Y.H., Kang E.S., and Kim S.K.  2006.  
Antidiabetic agents from medicinal plants.  Current Medicinal Chemistry, 13(10): 
1203–1218. 
 
Kedei N., Lundberg D.J., Toth A., Welburn, P., Garfield, S.H., and Blumberg 
P.M.  2004.  Characterization of the interaction of ingenol 3-angelate with protein 
kinase C.  Cancer Research, (64): 3243–3255. 
 
24 
 
Kennedy D., and Whightman E.  2011.  Herbal extracts and phytochemicals: Plant 
secondary metabolites and enhancement of human brain function.  Advances in 
Nutrition, (2): 32–50. 
 
Kramer R., and Cohen D.  2004.  Functional genomics to new drug targets. Nature 
Reviews Drug Discovery, 3(11): 965– 972. 
 
Lambert R.J.W., Skandamis P.N., Coote P., and Nychas G.J.E.  2001.  A study of 
the minimum inhibitory concentration and mode of action of oregano essential oil, 
thymol and carvacrol.  Journal of Applied Microbioogy. (91): 453–462. 
 
Lee J.H., Koo T.H., Hwang B.Y., and Lee J.J.  2002.  Kaurane diterpene, 
kamebakaurin, inhibits NF-kappa B by directly targeting the DNA-binding activity of 
p50 and blocks the expression of antiapoptotic NF-kappa B target genes.  Journal of 
Biological Chemistry, 277(21): 18411–18420. 
 
Lee K.G., and Shibamoto T.  2000.  Antioxidant properties of the aroma 
compounds isolated from soyabean and mung beans.  Journal of Agriculture and 
Food Chemistry, (48): 4290–4293. 
 
Li M., Wei S.Y., Xu B., Guo W., Liu D.L., Cui J.R., and Yao X.S.  2008.  
Proapoptotic and microtubule-disassembly effects of ardisiacrispin (A+B), 
triterpenoid saponins from Ardisia crenata on human hepatoma Bel-7402 cells.  
Journal of Asian Natural Product Research, (10): 739–746. 
 
25 
 
Li Q., and Sham H.L.  2002.  Discovery and development of antimitotic agents that 
inhibit tubulin polymerisation for the treatment of cancer.  Expert Opinion on 
Therapeutic Patents, (12): 1663–1701. 
 
Mathias E., McCorkle C. M., and Schillhorn Van Veen T. W .  1996.  Introduction: 
Ethnoveterinary research and development. In McCorkle C.M, Mathias E. and 
Schillhorn van Veen T.W. (eds). Ethnoveterinary Research and Development .  
Intermediate Technology Publications. 
 
Mustafa N.R., and Verpoorte R.  2007.  Phenolic compounds in Catharanthus 
roseus.  Phytochemistry Reviews, (6): 243–258. 
 
Nam N.H.  2003.  Combretastatin A-4 analogues as antimitotic antitumor agents.  
Current Medicinal Chemistry, (10): 1697–1722. 
 
Newman D.J., Cragg G.M., Snader K.M.  2000.  The influence of natural products 
upon drug discovery.  Natural Product Reports, 17(3): 215–234. 
 
Newman D.J., Cragg G.M., and Snader K.M.  2003.  Natural products as sources 
of new drugs over the period 1981–2002.  Journal of Natural Products, 66 (7): 1022–
1037. 
 
26 
 
Newman, D.J and Cragg, G.M.  2005.  In Zhang, L., Fleming, A., and Demain, A.L., 
(Eds.) Drug Discovery, Therapeutics, and Preventive Medicine, Totowa, NJ, USA: 
Humana Press, p. 74. 
 
Ogbourne S.M., Suhrbier A., and Jones B.  2004.  Antitumour activity of ingenol 3-
angelate: Plasma membrane and mitochondrial disruption and necrotic cell death. 
Cancer Research, (64): 2833–2839. 
 
Ohsumi K., Nakagawa R., Fukuda Y., Hatanaka T., Morinaga Y., Nihei Y., Ohishi 
K., Suga Y., Akiyama Y., and Tsuji T.  1998.   Novel combretastatin analogues 
effective against murine solid tumors: Design and structure-activity relationships, 
Journal of Medicinal Chemistry, (41): 3022-3032. 
 
Patel D.K., Prasad S.K., Kumar R., and Hemalatha S.  2012.  An overview on 
antidiabetic medicinal plants having insulin mimetic property.  Asian Pacific Journal 
of Tropical  Biomedicine, 2(4): 320–330.  
 
Pinney, K.G., Jelinek, C., Edvardsen, K., Chaplin, D.J., and Pettit, G.R.  2005.  
The discovery and development of the combretastatins. In: Cragg, G.M., Kingston, 
D.G.I., Newman, D.J. (eds.), Anticancer Agents from Natural Products. Brunner-
Routledge Psychology Press, Taylor & Francis Group, Boca Raton, FL, pp. 23–46. 
 
27 
 
Polo M.P. and de Bravo M.G.  2006.  Effect of geraniol on fatty-acid and 
mevalonate metabolism in the human hepatoma cell line Hep G2. Biochemical Cell 
Biology, (84): 102-111. 
 
Prance G.T.  1994.  Ethnobotany and the Search for New Drugs. In Chadwick D J, 
Marsh J (Eds).  Chichester ; New York : J. Wiley, Chichester (Ciba Foundation 
Symposium 185): 1–3. 
 
Ramawat K.G., Dass S., and Mathur M.  2009.  The chemical diversity of bioactive 
molecules and therapeutic potential of medicinal plants.  In: Ramawat K.G (ed.), 
Herbal Drugs: Ethnomedicine to Modern Medicine, Berlin Heidelberg: Springer-
Verlag, p 7-32. 
 
Reymond P., Weber H, Damond M, Farmer EE.  2000.  Differential gene 
expression in response to mechanical wounding and insect feeding in Arabidopsis.  
Plant Cell. (12): 707–19. 
 
Robbers J., Speedie M., and Tyler V. 1996. Pharmacognosy and 
Pharmacobiotechnology. In: Williams and Wilkins (Eds), Baltimore. 
  
Rohmer M.  1999.  The discovery of a mevalonate-independent pathway for 
isoprenoid biosynthesis in bacteria, algae and higher plants. Natural Product 
Reports, (16): 565–74. 
 
28 
 
Rybicki E.P, Chikwamba R., Koch M., Rhodes J. I., and Groenewald J.H.  2012.  
Plant-made therapeutics: An emerging platform in South Africa. Biotechnology 
Advances, 2(30): 449–459. 
 
Sarker S.D., Latif Z., and Gray A.I.  2006. Methods in Biotechnology: Natural 
Product Isolation. In: Satyajit D.( Ed). Supercritical fluid extraction.  Totowa, NJ, 
USA: Human Press Inc, p. 528. 
 
Schuler P.  1990.  Natural antioxidants exploited commercially, In: Hudson B.J.F. 
(Ed.) Food Antioxidants, London: Elsevier, pp: 99–170. 
 
Shanley P., and Luz L.  2003.  The impacts of forest degradation on medicinal plant 
use and implication for health care in Eastern Amazonia.  BioScience; 53(6): 573–
584. 
 
Simpson  B.B. and Ogorzaly, M.C.  2001.  Economic Botany: Plants in our World. 
3rd edition. Boston: McGraw Hill. 
 
Sunanda P., and Anand K.  2003.  Possible amelioration of hyperthyroidism by the 
leaf extract of Annona squamosa.  Current  Science, (84): 1402–1404. 
 
Trojan-Rodrigues M., Alves T.L.S., Soares GLG, and Ritter M.R.  2011.  Plants 
used as antidiabetics in popular medicine in Rio Grande do Sul, southern Brazil.  
Journal of Ethnopharmacology, 139(1): 155–63. 
 
29 
 
Van der Merwe D, Swan GE, and Botha CJ.  2001.  Use of ethnoveterinary 
medical plants in cattle by Setswana-speaking people in the Madikwe area of the 
North West Province of South Africa. Journal of South African Veterinary 
Association, (72): 189-96. 
 
Vitrac X, Krissa S, Decendit A, Deffieux G, and Merillon JM.  2004.  Grapevine 
polyphenols and their biological effects. In: KG Ramawat (Ed.) Biotechnology of 
Medicinal Plants. Enfield, CT: Science Publishers, p 33. 
 
Wang S.Y and Jiao H.  2000.  Correlation of antioxidant capacities to oxygen radical 
scavenging enzyme activities in blackberry. Journal of Agriculture and Food 
Chemistry, (48): 5672–5676. 
 
Wess G., Urmann M., and Sickenberger B.  2001.  Medicinal chemistry: 
Challenges and opportunities.  Angewandte Chemie International Edition, 18(40): 
3341–3350. 
 
Wink M.  2003.   Evolution of secondary metabolites from an ecological and 
molecular phylogenetic perspective. Phytochemistry, (64): 3–19. 
 
Zenk M.H., and Juenger M.  2007.  Evolution and current status of the 
phytochemistry of nitrogenous compounds. Phytochemistry, (68): 2757–72. 
 
Zwenger S., and Basu C.  2008.  Plant terpenoids: Applications and future 
potentials.  Biotechnology and Molecular Biology. Reviews, (3): 001–007. 
30 
 
Chapter 2 
In vitro anti-cancer screening of Asparagus laricinus extracts 
 
2.1. Introduction 
 
Cancer is one of the most prominent diseases in humans and currently there is 
considerable scientific and commercial interest in the continuing discovery of new 
anti-cancer agents from natural product sources (Kinghorn et al., 2003).  Historical 
experiences with plants as therapeutic tools have helped to introduce single 
chemical entities in modern medicine.  Plants, especially those with 
ethnopharmacological uses, have been the primary sources of medicines for early 
drug discovery.  Current drug discovery from terrestrial plants has relied mainly on 
bioactivity-guided isolation methods, which, for example, have led to discoveries of 
important anti-cancer agents, paclitaxel from Taxus brevifolia and camptothecin from 
Camptotheca acuminate (Kinghorn, 1994). 
 
The search for natural products as potential anti-cancer agents dates back at least to 
the Ebers papyrus in 1550 BC.  However, the current study begins with 
investigations similar to those of Hartwell and co-workers in the late 1960s on the 
application of podophyllotoxin and its derivatives as anti-cancer agents (Hartwell, 
1967).   
 
Podophyllotoxin, a bioactive lignan, was first isolated by Podwyssotzki in 1880 from 
the North American plant Podophyllum peltatum Linnaeus (American podophyllum).  
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Two semisynthetic derivatives of podophyllotoxin, etoposide and teniposide, are 
currently used in frontline cancer chemotherapy against various cancers (O‟Dweyer 
et al., 1985).  Since the publication of Hartwell‟s findings on posophyllotoxin 
(Hartwell, 1967), natural products and their derived components as therapeutic 
agents, especially those from plant sources, have increased as a component of 
modern westernised medicine.  Similarly, there has been an increase in publications 
related to natural products, their chemistry, biological activities and uses. 
 
Currently, over 85 or 48.6% of drugs used in clinical trials for anti-cancer activity are 
actually derived from natural products or are natural products (Newman and Cragg,  
2012).  This demonstrates the rationale for the search for novel drug molecules in 
medicinal plants, especially when literature shows that plant-derived compounds 
have provided attractive possibilities for treatment strategies (Jain and Jain, 2011).   
 
The aim of the present study was to identify the anti-cancer activity of A. laricinus 
against three human cell lines, namely breast MCF-7, renal TK-10 and melanoma 
UACC-62.  These cell lines were selected because of their high sensitivity to detect 
anti-cancer activity.  The researcher demonstrated here that these extracts exhibit 
anti-cancer activity against the three human cell lines. 
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2.2. Materials and methods 
 
2.2.1. Plant material 
 
The plant material (A. laricinus) was authenticated by scientists at the National 
Botanical Gardens in Pretoria, South Africa.  The collected root materials were dried 
at room temperature, pulverised by a Macsalab mill (Model 200, LAB) and weighed. 
The powder was then stored at room temperature until analysis.  Plant material (10 g 
of the dried roots) was soaked in a volume of 500 ml of ethanol or purified water for 
72 hours under shaking conditions (120 rpms).  The supernatant was filtered 
passively through a Whatman® filter paper, 11 cm in diameter.  The solvent (ethanol) 
was removed completely under vacuum by using a speed evaporator (Univapo 
100H) at 50°C.  The aqueous sample was lyophilised for 72 hours in the VIRTIS 5 L 
freeze drier (VIRTIS New York, USA) to obtain a dried powdered plant extract. The 
dried samples were then reconstituted in either water or ethanol.  
 
2.2.2. In vitro anti-cancer screening 
 
The human cell lines TK-10, UACC-62 and MCF-7 were obtained from the National 
Cancer Institute (NCI) in the framework of a collaborative research program between 
the Council for Scientific and Industrial Research (CSIR) and the NCI.  The extracts 
and compounds were assayed in the three-cell line panel consisting of TK-10 (renal), 
MCF-7 (breast), and UACC-62 (melanoma) cells.  Cell lines were routinely 
maintained as monolayer cell cultures at 37°C, 5% CO2 and 100% relative humidity 
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in Roswell Park Memorial Institute (RPMI) media containing 5% fetal bovine serum, 
2 mM L-glutamate and 50 μg/ml gentamicin.  The primary anti-cancer assay was 
performed at the CSIR in accordance with the protocol of the Drug Evaluation 
Branch, NCI (Leteurtre et al., 1994; Kuo et al., 1993; Monks et al., 1991).  The 
extracts or compounds were tested at a single concentration (100 ppm) and the 
culture was incubated for 48 hours.  End-point determinations were made with a 
protein-binding dye, Sulforhodamine B (SRB). 
 
The growth percentage of the treated cells was evaluated spectrophotometrically 
versus controls not treated with test agents.  All the extracts that reduced the growth 
of two of the cell lines by 75% or more were tested further at 1/2 log serial dilutions 
of concentrations ranging from 6.25-100 ppm.  The blanks contained complete 
medium without cells and etoposide was used as a standard.  Results of five dose 
screenings were reported as total growth inhibition (TGI).  The biological activities 
were separated into four categories: inactive (TGI >50 ppm), weak activity (15 ppm< 
TGI <50 ppm), moderate activity (6.25 ppm< TGI <15 ppm) and potent activity (TGI 
<6.25 ppm), according to NCI guidelines. 
 
2.2.3. Analysis of results 
 
For each tested extract, one additional parameter was calculated: GI50 (50% growth 
inhibition, as opposed to TGI, which indicates 100% growth inhibition, indicates the 
cytostatic activity of the test agent).  
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2.3. Results  
 
The results obtained show significant growth inhibition of three human cancer cell 
lines by both ethanol and aqueous extracts (Figure 2.1 and 2.2).  However, the 
ethanol extract exhibited more potent anti-cancer activity, where 6.25 µg/ml of the 
extract inhibits 40% of both TK-10 and MCF-7. In contrast, it required 25 µg/ml of the 
aqueous extract to achieve the same results.  The UACC-62 cell line was the most 
susceptible to inhibition by both extracts of A. laricinus. 
 
  
Figure 2.1. Growth inhibitory effect of ethanol extracts of A. laricinus on three 
human cancer cell lines: MCF-7 (▲), TK-10 (▄) and UACC-62 (□). 
 
  
Figure 2.2. Growth inhibitory effect of aqueous extracts of A. laricinus on three 
human cancer cell lines: MCF-7(▲), TK-10(▄) and UACC-62 (□) 
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The ethanol extract exhibited superior activity to etoposide and aqueous extract on 
inhibition of the UACC-62.  The aqueous extract showed the lowest activity 
compared to both ethanol extract and etoposide; on all cell lines the activity status 
was moderate (Table 2.1).  The breast cancer cell line (MCF-7) was found to be 
resistant to etoposide, yet susceptible to both aqueous and ethanol extracts.  
Interestingly, the ethanol extract showed potent activity against the UACC-62 cell 
line, while maintaining moderate activity against TK-10 and MCF-7. 
 
Table 2.1. Cytotoxic activity (GI50 values) of plant extracts and etoposide that are 
used in the treatment of cancer cell lines   
Treatment MCF7 cell line TK-10 cell line UACC-62 cell line 
GI50 TGI Status GI50 TGI Status GI50 TGI Status 
Ethanol extract <6.25 8.04 Moderate 
activity 
<6.25 8.34 Moderate 
activity 
<6.25 <6.25 Potent 
activity 
Aqueous extract 27.25 52.83 Weak 
activity 
29.70 49.98 Weak 
activity 
19.59 27.99 Weak 
activity 
Etoposide <6.25 >100 Inactive  9.72 25.19 Weak 
activity 
<6.25 38.54 Weak 
activity 
 
2.4. Discussion 
 
The observed anti-cancer activity of water and ethanol extracts of A. laricinus at 50 
µg/ml concentrations is meaningful and profiles this plant as a potential source of 
therapeutic compounds.  The first report of the anti-cancer activity of A. laricinus was 
published by our research group (Mashele and Kalishnikov, 2010).  It is of interest 
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that the extracts of the plant showed cytotoxicity against the cancer cell line, and if 
this also occurs in vivo, the use of this plant by traditional healers for the treatment of 
cancer patients would have some scientific basis.   
 
The aqueous extract exhibits low anti-cancer activity compared to the ethanol 
extract.  The latter showed moderate activity while that of the former was weak.  
Organic solvents have the disadvantage of dissolving molecules that have poor 
bioavailability, the aqueous extract will be chosen for further experiments due to its 
suitability in mimic the extraction conditions of most traditional users of the medicinal 
plants.  Fabricant and Farnsworth (2001) argued that proper action needs to be 
taken to assure that potentially active constituents are not lost, distorted or destroyed 
during the preparation of the extract from plant samples, especially when the plant is 
selected on the basis of traditional usage. 
 
Pytochemicals isolated from medicinal plants are found to act as potent antioxidants 
and free radical scavengers.  These natural products are supposed to minimize 
deoxyribonucleic acid (DNA) damage by reacting with free radicals and in this way 
they could prevent cancer (Rao et al., 2008).  However, this does not suffice in this 
study, where the plant extract was found to be cytotoxic to cancer cell lines.  Thus, 
the next chapter will evaluate the mutagenic and cytotoxic effects of A. laricinus 
aqueous extract. 
 
A more plausible proposal of the anti-cancer mechanism of plant extracts is that the 
anti-cancer action of plants occurs via direct cytotoxic effects and/or indirectly 
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through immunological modulatory action (Kitakgishi et al., 2012).  However, this 
explanation offers no clarity in the cascade of reactions that could be involved. 
2.5. Conclusion 
 
It has been proven that both aqueous and ethanolic extracts of A. laricinus have anti-
cancer activity against TK-10 (renal), MCF-7 (breast), and UACC-62 (melanoma) cell 
lines.  Maximum activity was found in the ethanol extract of the plant.  However, the 
aqueous was chosen for further studies in order to be consistent with the traditional 
usage of the plant.  The aqueous extract of this plant has the potential to be used in 
dealing with the side effects of cancer. 
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Chapter 3 
Evaluation of the mutagenicity and cytotoxicity effect of Asparagus laricinus 
 
3.1. Introduction 
 
One of the most prominent diseases in humans today is cancer.  It is projected that 
deaths from cancer are continuing to escalate, with an estimated increase from nine 
million deaths from cancer in 2015 to 11.4 million deaths per year by 2030 (WHO 
report, 2005).  Generally, cancer begins after a mutational episode in a single cell 
and then it progressively transforms to malignancy in multiple stages through 
sequential acquisition of additional mutations (Khan and Pelengaris, 2006). 
 
Because mutation is an important factor in carcinogenesis, the incidence of cancer 
may be reduced by decreasing the rate of mutation.  The best way for humans to 
decrease the rate of mutation is to avoid exposure to or ingestion of mutagens and 
carcinogens (Kim et al., 2006).  Currently, there is marked scientific and commercial 
interest in the continuing discovery of new anti-cancer agents from natural product 
sources (Kinghorn et al., 2003).  More than 50% of drugs used in clinical trials for 
anti-cancer activity were isolated from natural sources or are related to them (Cragg 
and Newman, 2005; Newman and Cragg, 2007).  Hence, the search for natural 
products to be used in cancer therapy represents an area of great interest in which 
the plant kingdom is the most important source, providing many anti-tumor agents 
with novel structures and unique mechanisms of action (Chang et al., 1999). 
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Present chemotherapy cancer treatments have proved to be ineffective as a result of 
their toxicity and cells developing resistance (McWhirter et al., 1996; Balducci and 
Extermann, 2005).  Many conventional drugs also induce genetic damage that itself 
can be carcinogenic.  A segment of the research community is thus focusing on 
identifying novel chemotherapeutic agents in plants that do not induce the 
destructive effects of conventional cytotoxic therapeutic agents. 
 
Several medicinal plants are traditionally used in the treatment of a variety of 
ailments, including cancer, in many communities in South Africa and neighboring 
countries.  Since ancient times, herbal medicine has always been one of the main 
components of the health care system.  Plant compounds were initially used as a 
source of anti-cancer agents by Hartwell in 1967, he used podophyllotoxin and its 
derivatives as anti-cancer agents (Shams et al., 2012).  
 
Many of the plants in phytotherapy have not yet been scientifically assessed for their 
efficacy or safety to the tissue or organs of recipients.  Thus, investigation of 
traditionally used medicinal plants is valuable as a source of potential 
chemotherapeutic agents and also to assess the safety of the continuous use of 
medicinal plants.  As a result, many studies are being directed at popular medicine, 
with the aim of identifying natural products that exhibit therapeutic properties 
(Hamburger and Hostettmann, 1991; Weisburger, 1996).  Phenolic compounds and 
flavonoids are also widely distributed in plants that have been reported to exert 
multiple biological effects, including antioxidant and free radical scavenging abilities, 
as well as anti-inflammatory and anti-carcinogenic effects etc. (Patel et al., 2010; 
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Chu et al., 2000).  In this regard, this study will determine the phenolic content of A. 
laricinus aqueous extract. 
 
The Ames test (Maron and Ames, 1983; Mortelmans and Zeiger, 2000) was used in 
this study, as it is widely used in the determination of possible gene mutations 
caused by extracts.  A positive response in any single bacterial strain, either with or 
without metabolic activation, is sufficient to designate a substance as a mutagen 
(Zeinger, 2001).  The study being reported here evaluated the mutagenic and anti-
mutagenic activity of the water extract of A. laricinus roots, which are known to be 
used in the treatment of cancer. 
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3.2. Materials and methods 
 
3.2.1. Plant material 
 
The plant material (A. laricinus) was authenticated by scientists at the National 
Botanical Gardens in Pretoria, South Africa.  The collected root materials were dried 
at room temperature, pulverised by a mechanical mill and weighed. The powder was 
then stored at room temperature until analysis.  Plant material (10 g of the dried 
roots) was weighed, pulverised using a Macsalab mill (Model 200, LAB) and soaked 
in a volume of 500 ml of ethanol or purified water for 72 hours under shaking 
conditions (120 rpms).  The supernatant was filtered passively through a Whatman® 
filter paper, 11 cm in diameter.  The aqueous sample was lyophilised for 72 h in the 
VIRTIS 5 L freeze drier (VIRTIS New York, USA) to obtain a dried powdered plant 
extract.  The dried samples were then reconstituted in water or ethanol.  
 
3.2.2. The Ames test 
 
The Ames test is a well-known bacterial mutagenicity test (Weisburger, 1996; 
Mortelmans and Zeiger, 2000).  In this test, reverse His−→His+ mutations are 
visualized by plating Salmonella typhimurium bacteria in a histidine-poor growth 
medium.  In this medium only, His+ mutants are able to form visible colonies.  
Different bacterial strains are available to identify different types of mutations. The 
researcher used the strains TA97, TA98 TA100 and TA102.  The strains TA98 and 
TA100 are actually those that are most often used, as they detect the great majority 
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of mutagens. Strain TA98 gives an indication of frame-shift mutations, while a 
positive response from strain TA100 indicates base-pair substitution. Table 3.1 lists 
important characteristics of these mutant strains.  For a substance to be considered 
genotoxic in the Ames test, the number of revertant colonies on the plates containing 
the test compounds should be more than twice the number of colonies produced on 
the solvent control plates (i.e. a ratio above 2.0).  In addition, a dose response 
should be evident for the various concentrations of the mutagen tested.  Toxicity can 
be checked by investigation of the background layer of bacteria.  Anti-mutagenicity 
was expressed as percentage inhibition of mutagenicity according to the following 
formula given for the Ames test (Ong et al., 1986): 
% inhibition = [1 – T/M] x 100 
 
where T is the number of revertants per plate in the presence of mutagen and the 
test sample and M is the number of revertants per plate in the positive control 
(mutagen alone).  The same formula was also adopted for other tests.  An extract 
was considered to have no or only weak anti-mutagenic properties when the 
percentage inhibition of mutagenicity (e.g. revertants in the Ames assay) was less 
than 25%.  When the percentage inhibition was between 25% and 40% it was 
considered that the extract had a moderate anti-mutagenic effect and it was 
concluded that an extract had a strong anti-mutagenic effect when the percentage 
inhibition was higher than 40%.  Dimethyl sulfoxide was used as a negative control, 
while daunomycin (10 μl/plate) was used as a positive control.  All experiments were 
performed in triplicate.  The metabolic activation (S9) was donated by the MRC Liver 
Research Centre, Tygerberg, Cape Town. 
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Table 3.1. List of Salmonella typhimurium strains used in Ames test 
Strain Amino Acid Marker 
 Histidine 
mutation 
Type of 
mutation 
Main DNA target 
Salmonella 
typhimuriumTA97 
hisD6610 Frameshift rfa 
Salmonella 
typhimuriumTA98 
hisD3052 Frameshift rfa 
Salmonella 
typhimuriumTA100 
hisG46 Base pair 
substitution 
rfa 
Salmonella 
typhimuriumTA102 
hisG428 Base pair 
substitution 
rfa 
 
3.2.3. Determination of total phenolic content 
 
The total phenolic content in A. laricinus extract was determined employing Folin-
Ciocalteu reagent (Singleton et al., 1999), with minor adaptations.  Gallic acid was 
used as a standard phenolic compound.  In a test tube, 0.5 ml of plant extract (500 
µg/ml) or standard solution was added, followed by 35 ml of H2O and 2.5 ml of Folin-
Ciocalteu reagent. The content was mixed thoroughly. After eight minutes, 7.5 ml 
NaCO3 (10% w/v) was added. The mixture was allowed to stand in the dark for one 
hour. Absorbance was measured at 760 nm using a spectrophotometer (Biowave II, 
WPA). The concentration of total phenolic compounds in plant extracts was 
determined from the Gallic acid standard curve.  Data points were recorded in 
triplicate and the regression line was drawn with the aid of graphpad prism 5.0. 
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Figure 3.1. Standard curve of absorbance against Gallic acid concentration Y = 
0.003604*X + 0.1098, R2 = 0.9909. 
 
3.2.4. Cytotoxicity  
 
For the cytotoxicity assay, the cells were cultured in 96-well culture plates (Cellstar, 
Greiner Bio-One, Germany).  After incubation for 24 h at 37ºC, cells were exposed to 
increasing concentrations of the extracts.  Assays were carried out in triplicate.  
Monolayers incubated only with Eagle's Minimum Essential Medium (EMEM) were 
used as cellular controls.  The concentration of the extracts that reduced the viable 
cell number to 50% (IC50).  This colorimetric assay is based on the capacity of 
mitochondria succinate dehydrogenase enzymes in living cells to reduce the yellow 
water soluble substrate 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide 
(MTT) into an insoluble, colored formazan product, which is measured 
spectrophotometrically.  Since reduction of MTT can only occur in metabolically 
active cells, the level of activity is a measure of the viability of the cells. The IC50 
was measured by the MTT method (Mosmann, 1983).  Briefly, monolayers treated 
48 
 
with extracts for 48 h at 37ºC were incubated with MTT solution for four hours at 
37ºC. Subsequently, the supernatant was removed and acid-isopropanol (0.04N HCl 
in isopropanol) was added.  After gently shaking for 15 min, the absorbance was 
read on a multiwall spectrophotometer at 570 nm.  The optical density (OD) was 
measured at 560 nm using a microplate ELISA reader (Labsystems Multiskan MS, 
Finland).  The survival fraction percentage (SF %) in the treated cultures was 
calculated from the OD. In relation to culture controls, that represents 100% viability: 
OD treated cells 
SF % = ----------------------------- x 100 
OD control 
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3.3. Results 
 
3.3.1. Mutagenicity and anti-mutagenicity 
 
Incubation of Salmonella typhimurium standard tester strains TA97, TA98, TA100 
and TA102 with three serial dilutions without S9 metabolic activation showed 
percentage inhibition below 25% for both TA 97 and TA 102; with an increase in 
dilution the inhibition decreased (Table 3.2).  This trend continued even when the 
tester strains were incubated with both A. laricinus and daunomycin.  However, this 
decrease was not concentration-dependent.  The results revealed that A. laricinus 
extracts were non-mutagenic towards the Salmonella typhimurium strains TA97, 
TA98, TA100 and TA102 for the assay without metabolic activation.   
 
Table 3.2. Summary of mutagenic/antimutagenic properties of Asparagus 
laricinus aqueous extract. 
 
  Mutagen/anti-mutagen Mutagen + anti-mutagen 
Strain TA 97 TA 98 TA 100 TA 102 TA 97 TA 98 TA 100 TA 102 
Dilution Percentage inhibition Percentage inhibition 
 50x 21 49 28.6 22.7 20.2 23.4 31.6 37.5 
 100x 10.4 35.1 12.1 23.5 14.5 19.5 28.4 24 
 200x 9.1 21.9 19 21.5 7.6 17.1 15.5 21 
 
The Ames test without S9 metabolic activation can only detect direct mutagens, 
while S9 metabolic activation allows the detection of indirect mutagens, often caused 
by conjugation reactions of metabolic oxidation systems.  
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The Ames test is carried out by adding the S9 mix to detect an indirect mutagenic 
effect caused by metabolites of the test A. laricinus extract (Table 3.3).  The strain 
TA 102 showed higher colony plate count in A. laricinus extract treated cells 
compared to the negative control.  This suggests mutagenic activity from the extract.  
However, other tester strains (TA97, TA98, and TA100) showed lower counts in cells 
treated with extract than in the negative controls. 
 
The S9 fraction contains a mixture of xenobiotic metabolizing enzymes, such as the 
cytochrome P450s and sulfotransferase.  Asparagus laricinus extract showed an 
indirect mutagenic effect toward the tester strain TA102 after metabolic activation,  
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Table 3.3. Mutagenic activities of Asparagus laricinus aqueous extract with  
 
metabolic activation (+S9). 
S. typhymurium 
strain 
Dilution Plate count (Mean +/- 
SD) 
TA 97 50X 154 +/-7 
TA 97 100x 154+/-10 
TA 97 200x 163+/-12 
TA 97 control (+) n/a 351 
TA 97 control (-) n/a 351 
\TA 98 50x 40+/-6 
TA 98 100x 32+/-8 
TA 98 200x 45+/-6 
TA 98 control (+) n/a   830 
TA 98 control (-) n/a 53 
TA 100 50x 123+/-4 
TA 100 100x 131+/-3 
TA 100 200x 132+/-8 
TA 100 Control (+) n/a 1395 
TA 100 Control (-) n/a 183 
TA 102 50x 451+/-47 
TA 102 100x 406+/-51 
TA 102 200x 405+/-50 
TA 102 control (+) n/a 1395 
TA 102 control (-) n/a 391 
*SD is standard deviation of three repetitions in the experiment 
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3.3.2 Cytotoxicity  
 
The cytotoxic effect of the aqueous extract from A. laricinus was tested against Vero 
cells using colorimetric method MTT assay. All the cells were exposed to various 
concentrations: 0.976, 1.935, 3.906; 7.8125,15.625, 31.25, 62.50,  125.00, 250 and 
500 μg/ml (Figure 3. 2).   
 
 
Figure 3. 2. The cytotoxicity of different concentrations of A. laricinus  
aqueous extracts on the growth of Vero cells was examined 
using MTT assay.  
 
The IC50 was determined based on a concentration that induced 50% inhibition on 
the growth of the treated cells compared to the untreated cells in triplicate; 500 μg/ml 
was found to induce 50% inhibition of Vero cells.  The latter observation suggests 
some cytotoxic effect of the A. laricinus extract on the Vero cells.  
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3.4. Discussion 
 
The average His+ revertants observed for all the tester strains caused by the plant 
extract at all the concentrations without metabolic activation did not satisfy the 
criteria for mutagenicity. There was no notable dose-dependent increase in the 
number of revertants and the numbers of revertants were all either not equal to or 
more than twice that of the negative control (Bulmer et al., 2008).   
 
There was also no decrease in the number of revertant colonies to levels far below 
the negative control (spontaneous reversion), which could also be classified as toxic.  
The extract had moderate (28%-34%) inhibitory effects using Salmonella 
typhimurium TA100 strain.  The upper limit was observed beginning with mutagen 
and followed by the anti-mutagen (aqueous extract).   
 
The lower limit was observed beginning with an anti-mutagen followed by a 
mutagen.  When both mutagen and anti-mutagen were operative on commencement 
of a possible disease, 31% inhibition was observed.  Similarly, using Salmonella 
typhimurium TA102 strain, the extract showed a low to moderate inhibitory effect 
(24%-38%) at 500 µg/ml of aqueous extract.  The lower limit represented mutagen 
followed by anti-mutagen and the upper limit was observed when both mutagen and 
anti-mutagen were operative on commencement of a possible disease.  However, 
using Salmonella typhimurium TA97 strain, the extract had a low inhibitory effect 
(20%-22%).  
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The degree of inhibition was not affected by the mode of interaction of the mutagen 
and anti-mutagen.  Finally, the inhibitory effect was observed over a wide spectrum 
using Salmonella typhimurium TA98 strain (23%-49%).  The upper limit was 
observed beginning with a mutagen and followed by an anti-mutagen.  The lower 
limit was observed when there was simultaneous interaction between a mutagen and 
the extract.  When both mutagen and anti-mutagen were operative on 
commencement of a possible disease, 35% inhibition was observed.  The significant 
anti-mutagenic activity of the plant extract against direct-acting mutagen suggests 
that the extract may directly mitigate events that lead to DNA damage from 
mutagens (Mussarat et al., 2006; Edenharder and Grunhage, 2003).  
 
The cytotoxicity tests indicated no cytotoxic effect below 500 μg/ml concentration of 
the A. laricinus aqueous extract.  This is promising, if the therapeutic benefit would 
have increased substantially before the 500 μg/ml dose is reached in in vivo studies.  
 
The Folin-Ciocalteu method confirmed the total phenolic content in the extracts.  
These are presented as Gallic acid equivalents (GAE) with reference to the Gallic 
acid standard curve, which was plotted using the average absorbance values of two 
independent sets of data against concentrations of Gallic acid in g/l.  The A. laricinus 
aqueous extract contained 4.2 g/l GAE.  Polyphenols are the most abundant dietary 
antioxidants and research on their role in the prevention of degenerative diseases 
and cancer has developed quickly over the last few years (Yang et al., 1998).  With a 
transgenic adenocarcinoma of the mouse prostate model of prostate carcinogenesis, 
it was recently demonstrated that oral consumption of 10 g/l of green tea 
polyphenols decreased tumor incidence by 65% (Gupta et al., 2001).  This 
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polyphenol preparation was enriched with epigallocatechin-3-gallate (62%), 
epicatechin-3-gallate (24%), epigallocatechin (5%), epicatechin (6%) and caffeine 
(„1%).  It is worth mentioning that the ratio of individual constituent polyphenols may 
vary from plant to plant.  In a previous chapter the anti-cancer activity of A. laricinus 
aqueous and ethanol extracts on cancer cell lines was demonstrated.   
 
Many researchers have inferred the anti-mutagenic activity of plant extract to the 
antioxidant activities of the polyphenols.  However, there has now been a paradigm 
shift as a result of a study that showed Asparagus racemosus extracts induced 
excessive production of TNF-alpha compared to controls (Katiyar et al., 1997). 
Naturally, white blood cells produce TNF-alpha protein to stimulate and activate the 
immune system in response to infection or cancer. Literature suggests that the mode 
of action of many plant extracts ranges between scavenging for free radicals and 
modulation of the immune system.  The evidence obtained in studies of a tea 
polyphenol, i.e. (-)-epigallocatechin gallate [(-)-EGCG], indicates that plant 
polyphenols target many enzymes directly associated with cancer, e.g. proteosome, 
telomerase, growth factors, MAPKs, etc (Nasaani et al., 1998; Hofmann and 
Sonenshein, 2003; Mukhtar and Ahmad, 1999; Chen et al., 2003).  
 
3.5. Conclusion 
 
A. laricinus polyphenol extract exhibited dose-dependent anti-mutagenic activity.  
The plant extract showed no mutagenic effect on most of the tested strains. 
However, mutagenic activity was observed with metabolic activation for the TA 102 
tester strain only, to the exclusion of TA97, TA98 and TA100.  These results indicate 
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the potential for use of this plant against cancer, despite the moderate cytotoxicity at 
500 μg/ml concentration.  The results obtained may aid in the development of anti-
cancer drugs from A. laricinus aqeous extract.   
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Chapter 4 
Evaluation of the antimicrobial, antiradical and antioxidant activities of 
Asparagus laricinus aqueous extract 
 
4.1. Introduction 
 
Plant-derived phytochemicals with dual functionalities in preventing lipid oxidation 
and microbial growths have tremendous potential use in phytotheraphy and/or the 
food industry.  Several bioactive flavonoids, such as furocoumarins and 
furanocoumarins, have been isolated from parsley leaf and are known to exhibit 
antibacterial activities against both Gram-positive Listeria and Micrococcus species 
and Gram-negative Escherichia and Erwinia species (Manderfield et al., 1997; Ulate-
Rodriguez et al., 1997).  Some natural phenolic antioxidants such as caffeic acid, p-
coumaric acid, chlorogenic acid and ferulic acid exhibit antimicrobial activity (Garrote 
et al., 2004).  Thus, in investigating the biological activities of medicinal plants, it 
becomes important to determine both the antimicrobial and antioxidant activities. 
 
The validity of the term “antioxidant” depends on the environment of its action, i.e. 
whether one considers an in vitro or in vivo action.  In this context a precise definition 
of conditions and processes in which antioxidant action is studied becomes crucial.  
Outside this context, a statement that some compound is an antioxidant may not 
yield any biologically meaningful information (Tirzitis and Bartosz, 2010).  Thus, this 
study evaluated anti-oxidative stress, as opposed to antioxidant activity.  
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Free radicals and reactive oxygen species in general are no longer seen only as 
destructive factors but also (and perhaps first of all) as messengers involved in 
intracellular and intercellular signaling (Bartosz, 2005; Halliwell, 2006).  The revision 
of the ideas on the role of free radical reactions in the functioning of cells and 
organisms has led to a new concept of redox equilibrium. 
 
According to this hypothesis, oxidative stress is a modulation of thiol redox reactions, 
involved mainly in signaling pathways.  Therefore, non-radical oxidants 
(enzymatically generated hydrogen peroxide, other peroxides, quinones, etc.) play a 
basic role in the oxidation of thiols for the sake of signaling, without the necessity of 
formation of free radical intermediates (Ghezzi et al., 2005; Jones, 2006; 2008).  
Thus, this study will evaluate both the ability to scavenge free radicals (antiradical 
activity) and the ability to protect the cell from oxidative stress (antioxidant activity) 
as mutually exclusive activities.    
 
The aim of this chapter is to evaluate the antimicrobial, antiradical and antioxidant 
activities of the A. laricinus aqueous extract.   
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4.2. Materials and methods 
 
4.2.1. Antimicrobial activity 
 
Prior to the test, bacterial and fungal cultures were prepared as described below. 
The bacterial cultures were sub-cultured in nutrient broth (Muller-Hutton) at 37oC for 
24 hours.  The turbidity of the broth culture was then equilibrated with 0.5 McFarland 
standard solution. 
 
The minimum inhibitory concentration (MIC) of the aqueous extract was determined 
by a colorimetric assay.  In a 96-well plate, five columns were used, designated 
“experimental”, and five wells in each column were filled with the same concentration 
of extract.  Three rows in a column were used for negative control (sterile water), 
another three rows in a column were used for positive control (gentamicin), and two 
wells were used for sterility control (Figure 4.1).   
 
Bacteria were prepared as described above (approx. 1 × 108 CFU/ml) to provide 
enough stock to fill all plates for all extracts tested (i.e. all of the tests involving a 
single bacterium species were performed on the same day).  Then, 100 μl of broth 
culture was placed into each well, except the sterility control wells, and 100 μl of the 
plant extract at concentrations of 100, 50, 25, 12.5 and 6.3 were added in all wells 
designated experimental, 100 μl positive control (10 mg/ml of gentamicin) and 
negative control (sterile water) were also added in their respective wells.  The 
positive control cell (gentimicin) should have no bacterial activity and remain clear, 
whereas the negative control cell (water) should have bacterial activity and change 
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to red, providing reference points for the visual analysis of the inhibitory effects of the 
extract dilutions.  The control column only contained 100 μl of the positive control 
(gentamicin), negative control (water), and extraction dilution solutions (i.e. identical 
to the experimental column except that no bacteria were present). Plates were 
prepared in triplicate such that each extract-bacteria combination was replicated 
across 96-well plates.  Plates were covered and incubated at 37°C for 24 hours. 
After the 24-hour incubation, 40 μl of a 0.2 mg/ml iodonitrotetrazolium violet (INT) 
indicator solution was simultaneously added to every well and the plate was 
incubated at 37°C for an additional 30 minutes.  The INT indicator solution changes 
from clear to red in the presence of bacterial activity and the degree of redness is a 
good measure of inhibitory effects (Eloff, 1998).  Following the 30-minute incubation, 
plates were digitally photographed.  
 
4.2.2. Thin layer chromatography analysis and antioxidant activity of extract 
constituents 
 
Qualitative screening for antioxidant activity was done using 2, 2-diphenyl-1-
picrylhydrazyl (DPPH), according to Tomohiro et al. (1994).  Thin layer 
chromatography (TLC) of extracts was developed with the mobile phase that was 
made of three solvents, namely methanol:chloroform:hexane (70:20:10%).  The 
stationary phase was made of silica gel GF254 (Fluka, 20x20 cm
2).  The plates were 
air-dried and sprayed with 0.05% DPPH in methanol.  Antioxidant activity was 
detected on the chromatogram by the appearance of yellow spots produced by 
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bleaching of DPPH (Bors et al., 1992).  All detected active antioxidant constituents 
were noted according to their retention factor (Rf) values. Gallic acid was used as 
positive control. 
 
4.2.3. Free radical scavenging activity  
 
The free radical scavenging activity of the A. laricinus extracts was analyzed by 
using DPPH assay (Von Gadow et al., 1997; Fuhrman et al., 2001).  Different 
concentrations (between 10-1x10-04 mg ml-1) of the extract were prepared. Aliquots 
(100 μl) of the extract or standard solution (Trolox® and ascorbic acid) were mixed 
with 2 ml of 0.1 mmol l-1 methanolic solution of DPPH radical. The tubes were mixed 
and allowed to stand for 60 minutes in the dark.  Absorbance was read against a 
blank at 517 nm using a spectrophotometer (Biowave II, WPA).  Methanol was used 
as a blank, while 6-hydroxy-2,5,7,8- tetramethylchroman-2-carboxylic acid (Trolox®) 
and ascorbic acid were used as positive controls.  All determinations were performed 
in triplicate.  The percentage inhibition of the DPPH radical by the extracts was 
calculated according to the equation used in Turner et al. (2011): 
Inhibition (%) = [1- (As/A0)]x100 
where As is the absorbance of the sample (i.e., extracts or standard) and A0 is the 
absorbance of the DPPH solution. The EC50, defined as the concentration of the 
sample leading to 50% of the reduction of the initial DPPH concentration, was 
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determined at 95% confidence interval, using GraphPad Prism® software.  The data 
on regression graphs represents Mean+/-SEM (standard error of means).  The 
experiment was done in triplicate. 
 
4.2.4. Oxidative stress 
 
Saccharomyces cerevisiae BY4742 strain was grown in YPD (2% glucose, 2% 
pepetone and 1% yeast extract) agar plate.  A single colony was picked and 
inoculated in 5ml YPD broth and incubated at 30oC under shaking conditions (120 
rpms) overnight.  This served as the pre-inoculum. 
 
From the overnight culture 100 μl of the pre-inoculum was transferred into a fresh 
medium.  The cells were grown to the exponential phase and harvested when the 
OD of the culture at 610 nm (O.D610 nm) reached 0.1 absorbance units.  At an OD of 
0.1 (representing approximately 1.8 x 106 viable cells ml-'), cells were harvested by 
centrifugation at 25 "C (4000 x g for 5 minutes) and resuspended in (5 ml) fresh YPD 
broth.  Three samples were treated with 10 mM concentration of H2O2 and 100 μg/ml 
of aqueous extract; three other samples were treated with H2O2 (10 mM) and three 
untreated samples served as negative control.  Aliquots (100 μl) were taken at 30-
minute intervals over a period of 1 hour and 30 minutes, diluted in YPD media and 
plated on YPD plates to obtain viable cell counts.  The method was adapted from 
Izawa et al. (1995).  
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4.3. Results 
4.3.1 Minimum inhibitory concentration  
 
The antimicrobial activity of the A. laricinus aqueous extract was remarkable against 
the eight clinical strains of bacteria.  The result of the antimicrobial activity, presented 
in Table 4.1, shows that the lower MIC plant extract was required for the Gram-
positive bacteria Bacillus subtilis ATCC 269153 (B. subtilis), Streptococcus 
pneumonia ATCC 6301 (S. pneumonia) and Staphylococcus aureus  ATCC 29213 
(S. aureus) .  
   
Table 4.1. Antimicrobial activity of the aqueous extract of Asparagus laricinus  
against selected clinical strains of bacteria . 
Microorganism Gram-staining 
property 
(MIC) μg/ml 
Proteus vulgaris ATCC6386 Negative 100 
Proteus mirabilis 
ATCC12453 
Negative 100 
Streptococcus pneumonia 
ATCC 6301 
Positive 50 
Pseudomonas aeruginosa 
ATCC 10145 
Negative 100 
Staphylococcus aureus 
ATCC 29213 
Positive 25 
Haemophilus influenza 
ATCC 1193 
Negative 100 
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Escherichia coli ATCC 
133762 
Negative 100 
Bacillus subtilis ATCC 
269153 
Positive 50 
*American type culture collection (ATCC)  
*Gentamicin was used as a positive control 
 
S. aureus was the only tested strain that was inhibited by 25 μg/ml of the plant 
extract.  This was contrary to the 100 μg/ml that was required for all Gram-negative 
strains (Pseudomonas aeruginosa ATCC10145 (P. aeruginosa), Proteus vulgaris 
ATCC 6386 (P. vulgaris), Escherichia coli ATCC 133762 (E. coli) and Proteus 
vulgaris ATCC 6386 (P. vulgaris)) and the 50 μg/ml in Gram-positive strains such as 
Streptococcus pneumonia (Figure 4.1). 
 
Figure 4.1. A digital photograph of the Streptococcus pneumonia ATCC 6301 
treated with an increasing concentration of A. laricinus aqueous 
extract.   
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4.3.2. Thin layer chromatography analysis and antioxidant activity of extract’s 
constituents  
 
Figure 4.2 shows the TLC chromatogram for the qualitative screening for 
antioxidants. Three spots with Rf of 0.87, 0.38 and 0.35 exhibited antioxidant activity 
when sprayed with DPPH. This indicated differences in the polarity of the separated 
antioxidant molecules. 
 
Figure 4.2. Chromatogram of Gallic acid (1) and A. laricinus aqueous extract (2 
and 3, lane 2 is a twofold dilution of lane 3), separated with 
methanol:chloroform:hexane (70:20:10%) and sprayed with DPPPH. 
The yellow spots indicate antioxidant activity (Rf values: a = 0.87; b = 
0.38; c = 0.35). 
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4.3.3.  Free radical scavenging activity 
 
The addition of the A. laricinus extract to the DPPH solution induced a rapid 
decrease in absorbance at 517 nm, indicating free radical scavenging activity of the 
extract (Fig. 4.3).  The EC50 value of the extract was recorded to be between 0.9205 
and 1.188 mgml-1 and was higher than that of Trolox® (Figure 4.3d).  The radical 
scavenging activity of the extract was concentration-dependent and similar to that of 
known antioxidants (Figure. 4.3a, b and c).  A. laricinus showed concentration-
dependent free radical scavenging activity at concentrations above 1 mg ml-1, while 
ascorbic acid no longer showed increasing activity above the same concentration. 
 
Figure 4.3 (a-d). Scavenging activity of A. laricinus aqueous extract on the free 
radical DPPH.  (a) A. laricinus, (b) Trolox®, (c) ascorbic acid, 
and (d) EC50 shift graph of A. laricinus extract with Trolox
® as 
the control.  
72 
 
4.3.3. Oxidative stress 
 
Figure 4.4, illustrates the response of Saccharomyces cerevisiae (BY4742) cells to 
hydrogen peroxide treatment.    
 
Figure 4.4. Yeast cell (BY4742) sensitivity to hydrogen peroxide.  Exponentially  
growing yeast cells (30oC) were treated with 10 mM (H2O2) for 90  
minutes.  Cells treated with H2O2 only (▲), untreated cells (●) and cells  
treated with H2O2 and aqueous extract (■). 
 
Cells that were incubated in hydrogen peroxide only showed a significant decrease 
in colony-forming units per milliliter (CFU/ml) after 30 minutes. This is contrary to the 
slight increase in colony-forming units in the cells that were incubated in hydrogen 
peroxide and aqueous extract.  As expected, the untreated cells grew exponentially 
from the same incubation period. 
 
4.4. Discussion 
 
MICs are considered the gold standard for determining the susceptibility of 
organisms to antimicrobials and are therefore used to judge the performance of all 
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other methods of susceptibility testing. MICs are used in diagnostic laboratories to 
confirm unusual resistance, to give a definite answer when a borderline result is 
obtained by other methods of testing or when diffusion methods are not appropriate 
(Andrews, 2001). 
 
Inhibition of Staphylococcus aureus ATCC 29213 by the A. laricinus plant extract 
demonstrates huge potential for the use of the plant in the treatment of microbial 
infections, especially in light of the growing antibiotic resistance in microoganisms. 
The best known example of an antibiotic resistance mechanism is probably the 
alternative penicillin-binding protein (PBP2a), which is produced in addition to the 
“normal” penicillin-binding proteins by methicillin-resistant Staphylococcus aureus  
(Hawkey, 1998).  The observed antibacterial activity of the extract suggests a 
possible antibiotic against such resistant strains of S. aureus. 
 
The growth inhibition of Pseudomonas aeruginosa ATCC 10145 and Escherichia coli 
ATCC 133762 is important, since it has been reported that patients with neutropenia 
are found to suffer from infection by the two bacteria mentioned (Schimpff et al., 
1971; Cometta et al., 1996).  These results show huge potential in alleviating 
infection by both Gram-negative and Gram-positive clinical strains.  
The antioxidant capacity of crude drugs is widely used as a parameter for evaluating 
medicinal bioactive components.  The present study has demonstrated the 
antiradical activity of A. laricinus.  The researcher observed three spots that 
exhibited antioxidant properties on the TLC chromatograms.  The characteristics of 
the three different antioxidants observed in the A. laricinus extracts are yet to be 
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elucidated.  The antioxidant in the plant extract may largely be due to polyphenols 
(Thabrew et al., 1998).  Phenolics are the largest group of phytochemicals and most 
antioxidant activity of plants or plant products is attributed to them.  Many studies 
have shown that natural antioxidants are able to reduce DNA damage, mutagenesis 
and carcinogenesis.  These events are often associated with the termination of free 
radical propagation in biological systems (Covacci et al., 2001; Zhu et al., 2002).  
The effect of antioxidants on DPPH radical scavenging is thought to be due to their 
hydrogen-donating ability or radical scavenging ability (Baumann et al., 1979).  
Considering the fact that the A. laricinus extract used was crude and the comparison 
was not on the basis of molar concentration, the above results are promising, despite 
having a higher EC50 value than Trolox
®. 
 
H2O2 and superoxide anions (O2
-) are often referred to as reactive oxygen species 
(ROS) as they can lead to production of more reactive species, particularly in the 
presence of metal ions.  ROS are generated endogenously in many cells as a 
consequence of metabolic processes.  ROS can also be formed by exposure of cells 
to ionizing radiation, redox-cycling chemicals present in the environment or by 
exposure to heavy metals (Ames, 1983; Brennan and Schiestl, 1996).  Through such 
mechanisms, all aerobically growing organisms are continuously exposed to reactive 
oxidants and oxidative stress occurs when the concentration of these oxidants 
increases beyond the antioxidant buffering capacity of the cell.  A side effect of 
respiration in organisms is the production of ROS that can damage proteins, lipids 
and DNA (Hererro et al., 2008). 
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The ability to protect Saccharomyces cerevisiae (S. cerevisiae) from oxidative stress 
is seen as valuable to understanding the potential effect of the plant extract to 
humans, since yeasts are  eukaryotic cells and are  equipped with several elaborate 
defense mechanisms against different types of stress imposed by the environment, 
and many of these are similar to mechanisms in higher organisms.   
 
4.5. Conclusion 
 
The aqueous extract of A. laricinus showed significant activity as an antioxidant.  It 
showed free radical scavenging activity comparable to Trolox and ascorbic acid.  
The antimicrobial activity of the aqueous extract indicated potential use of the plant 
in the treatment of microbial infections.  A. laricinus aqueous extract has the ability to 
protect cells from oxidative stress. 
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Chapter 5 
Chemical composition of both aqueous and methanol extracts of Asparagus 
laricinus  
 
5.1. Introduction 
 
Most medicinal plants are harvested from the wild and the production of medicinal 
metabolites in plants is affected by plant genotype, cultivation, harvesting, 
processing and distribution (Crozier, 2006). It has also been noted that the age of the 
plant, the presence of flowers or pods, different geographical origin, soil and climate 
play roles in plant adaptation mechanisms (Green, 1997).  Because of that, the level 
of metabolites represents integrative information of the cellular function and hence 
defines the phenotype plant in response to genetic or environmental changes (Silas 
et al., 2004). 
 
Since individual plant species have been known to manufacture over 100 000 
secondary metabolites (Yuliana et al., 2011), robust techniques that are able to 
analyze these large numbers of metabolites in the shortest time possible are useful 
in profiling.  There is growing interest in correlating the phytochemical constituents of 
a medicinal plant with its pharmacological activity (Prachayasittikul et al., 2008; 
Turker and Usta, 2008; Nogueira et al., 2008). Many biologically active compounds 
isolated from plants lead to the discovery of new medicinal drugs, which play efficient 
protection and treatment roles against various diseases, including cancer (Sheeja 
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and Kuttan, 20O7; Mukherjee, 2007). Thus, screening of plant extracts for important 
biological activities remain crucial in the search for novel molecules with relevant 
biological activities. 
 
The widespread use of liquid chromatometry – mass spectrometry (LC-MS) for 
global metabolic profiling is relatively new and the  literature indicates that MS-based 
techniques, particularly in combination with chromatographic technologies, are most 
popular, as these combine very high analytical precision with equally high detection 
sensitivity (Lenz and Wilson, 2007; Wilson et al., 2005).  Electro-spray ionisation 
(ESl) is one of the most frequently used soft ionisation techniques in MS. ESI 
eliminates the need for neutral molecule volatilization prior to ionization. In the 
negative mode, ESI spectra of the phenolics show a predominant molecular ion [M-
H] with minimum fragmentation. It is known that the negative ion mode generally 
provides improved detection limits (Ryan et aI., 1999).  It is argued that HPLC-MS 
offers some advantages over the gas chromatography- (GC) MS techniques 
currently used in metabolomics.  In particular, the ability to run samples with minimal 
sample preparation by HPLC-MS is in contrast to the more extensive sample pre-
treatment techniques that are sometimes required to obtain comprehensive 
metabolite fingerprints by GC-based techniques (Wilson et al., 2005). 
 
Based on the literature search, no report is available on the detailed analyses of the 
A. laricinus plant extract. Therefore, the aim of this chapter is to examine the 
chemical composition of both aqueous and methanol extracts.   
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5.2. Materials and methods 
 
5.2.1. Phytochemical screening 
 
Chemical tests were carried out on the aqueous and methanol extracts of A.  
laricinus. The samples were first powdered as explained in chapter 2 and subjected 
to the chemical tests described below (Edoaga et al., 2005). 
 
5.2.2. Alkaloid determination using Harborne (1973) method  
 
Five grams (5 g) of the sample was weighed into a 250 ml beaker and 200 ml of 10% 
acetic acid in ethanol was added, covered and allowed to stand for four hours. This 
was filtered passively through a Whatman® filterpaper, 11 cm diameter.  The extract 
was concentrated in a water bath to one-quarter of the original volume. Concentrated 
ammonium hydroxide was added dropwise to the extract until the precipitation was 
complete. The whole solution was allowed to settle and the precipitate was collected 
and washed with dilute ammonium hydroxide and then filtered. The residue was the 
alkaloid, which was air-dried and weighed. 
 
5.2.3. Test for tannins 
 
About 0.5 g of the dried powdered samples was boiled in 20 ml of water in a test 
tube and then filtered through a Whatman® filter, 11 cm diameter. A few drops of 
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0.1% ferric chloride was added and observed for brownish green or a blue-black 
coloration. 
 
5.2.4. Test for saponin 
 
About 2 g of the powdered sample was boiled in 20 ml of distilled water in a water 
bath (set at 100oC) and filtered though a. Whatman®, 11 cm diameter.  Then 10 ml 
of the filtrate was mixed with 5 ml of distilled water and shaken vigorously for a 
stable persistent froth.  The frothing was mixed with three drops of olive oil and 
shaken vigorously, then observed for the formation of emulsion. 
 
5.2.5 Test for steroids 
 
Two milliliters of acetic anhydride was added to 0.5 g ethanolic extract of each 
sample with 2 ml H2S04.  The color changed from violet to blue or green in some 
samples, indicating the presence of steroids. 
 
5.2.6. Test for terpenoids (Salkowski test) 
 
After mixing 5 ml of each extract in 2 ml of chloroform, concentrated H2S04 (3 ml) 
was carefully added to form a layer.  A reddish brown coloration of the interface was 
formed to show positive results for the presence of terpenoids. 
 
 
85 
 
5.3. Gas chromatography-mass spectrometry  
 
GC/MS analysis was carried out on a Shimadzu 2010 QB gas chromatograph with a 
MSD detector equipped with an HP-5 fused silica capillary column (30 m x 0.25 mm 
x 25 m film thickness).  The aqueous plant extract was injected via an all-glass 
injector working in split mode with helium as the carrier gas at a flow rate of 1 mL 
min-1. The oven temperature was programmed as follows: Injector temperature 
2000C, ion source 2000C, interphase 2000C. The column temperature was raised to 
45°C (3 minutes hold at 45°C, 4 minutes), then gradually increased to 150°C (3 
minutes hold at 150°C, 4 minutes) then raised to 250°C and a 15-minute hold. A split 
ratio of 1:5 was used (Ajayi et al., 2011).  Compound identification was accomplished 
by comparing the retention times with those of authentic compounds or the spectral 
data obtained from the Wiley Library and National Institute of Standards and 
Technologies Library, as well as with data published in the literature. 
 
5.4. Liquid chromatography/mass spectometry  
 
The plant extracts were resuspended in 1 ml of a 50% (v/v) mixture of acetonitrile 
and H2O containing 0.1% (v/v) formic acid.  The suspensions were vortexed for 1 
minute then sonicated for 5 minutes, vortexed again for 1 minute prior to 
centrifugation at 10 000 rpm for 10 minutes.  The supernatant (3 μl) was injected into 
the LC-MS instrument. Metabolites were separated using a gradient of H2O with 
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0.1% formic acid (solvent A) and acetonitrile (solvent B), using a Waters UPLC at a 
flow rate of 0.4 ml min-1 on a Waters BEH C18, 2.1x50 mm column.  MS was 
obtained on a Waters SYNAPT™ G2 MS (Manchester, England) using ESI running 
in positive mode with a cone voltage of 15 V.  The injections were repeated once to 
ensure repeatability.  
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5.5. Results 
 
5.5.1 Phytochemical screening 
 
Phytochemical screening of the aqueous extract was positive for the presence of 
alkaloids, saponins, tannins and terpenoids.  However, the ethanolic extract only 
tested positive for tannins and negative for the rest of the tests (Table 5.1). 
Table 5. 1. Phytochemical screening of aqueous and ethanol extracts of the roots 
of A. laricinus for different molecular constituents 
 
Key: -: Negative (absent): +: Positive (present) 
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5.5.2 Gas chromatography-mass spectrometry  
 
The GC-MS chromatogram gave rise to three peaks, suggesting the existence of 
three secondary metabolites and percentage values of composition of these 
phytochemicals present in the aqueous root extract of A. laricinus.  The results 
suggested the presence of indole-3-carbinol, α-sitosterol and ferulic acid, as shown 
in Figure 5.1. 
 
Figure 5.1. GC/MS chromatogram of the aqueous extract of A. laricinus roots 
 
5.5.3 Liquid chromatography/mass spectometry  
 
Typical positive and negative ion LC-MS chromatograms for a both aqueous and 
ethanol extracts of A. laricinus (Figures 5.2 and 5.3).  The major peaks in each 
solvent extract differed significantly, thus showing the effluence of solvents on 
excluding other of molecules during extraction. 
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Figure 5.2. Representative LC-MS chromatograms for ethanol extract (a) and 
aqueous extract (b) in negative ion electrospray. 
 
The aqueous constituents eluted in the predominantly polar regions of the solvent 
gradient, while ethanol extract constituents appeared in the non-polar region.  
 
 
(a) 
(b) 
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Figure 5.3. Representative LC-MS chromatograms for ethanol extract (a) and 
aqueous extract (b) in positive ion electrospray. 
 
Various compounds were identified based on their respective molecular formulae 
(Tables 5.2 and 5.3).  The tentative names and putative structures were obtained by 
searching for structures and names corroborating the molecular formula and the 
possible double bonds/carbon rings as reflected by the reported (double bond 
equivalent) DBE.  
 
 
 
 
 
(b) 
(a) 
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Table 5.2. Analysis of LC/MS chromatograms of A. laricinus ethanol extract 
Retention 
time (min) 
Fragmentation 
ion (M/Z) 
Molecular 
formula 
Tentative 
identification 
Putative structure 
5.8 263.1275 C15H19O4 
 
5-(1-Hydroxy-2,6,6-
triméthyl-4-oxo-2-
cyclohexén-1-yl)-3-
méthyl-2,4-
pentadiénoate 
 
http://www.chemspider.c
om/Chemical-
Structure 
 
 
http://www.chemspider.co
m/Chemical-Structure 
 
6.3 277.1435 C16H21O4 
 
4-(2-Methoxyphenyl)-
2,2-
dimethyltetrahydro-
2H-pyran-4-
yl]acetate 
 
http://www.chemspider.c
om/Chemical-
Structure 
 
 
http://www.chemspider.co
m/Chemical-Structure 
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7.8 265.1431 C15H21 O4 No inference No inference 
8.4 279. 1594 C16H23O4 4-(4-
(Hexyloxy)phenyl]-
4-hydroxybutanoat 
http://www.chemspider.c
om/Chemical-
Structure 
 
 
 
http://www.chemspider.co
m/Chemical-Structure 
 
 
 
 
Table 5.3.  Analysis of LC/MS chromatograms of A. laricinus aqueous extract 
Retention 
time (min) 
Fragmenta-
tion ion (M/Z) 
Molecular 
formula 
Tentative 
identification 
Putative structure 
2.0 380.2073 C20H30O6 1,4-bis(2-
hydroxymethyl-5,5-
dimethyl-1,3-
dioxan-2-
yl)benzene 
http://www.chemspid
er.com/Chemical-
 
http://www.chemspider.co
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Structure 
 
m/Chemical-Structure 
 
2.8 305.1148 C15H17 N2O5 1-Amino-2-(3,4-
dimethoxyphenyl)-
N-(2-
furoyloxy)ethanimin
ium 
http://www.chemspid
er.com/Chemical-
Structure 
 
 
http://www.chemspider.co
m/Chemical-Structure 
 
3.8 556.2529 C34H38 N4O4S 1,4,6,7-tétrahydro-
8H-pyrazolo[3,4-
e][1,4]thiazépin-8-
yl]-N-
isobutylacétamide 
http://www.chemspid
er.com/Chemical-
Structure 
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m/Chemical-Structure 
 
 
4.1 616.2509 C39H38 NO4S 5-(3,4,5-
Trimethoxyphenyl
)-3-(4-
dimethylaminophe
Not assigned 
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nyl)-6-(4-
phenoxyphenyl)-2-
phenyl-3,3a,5,6-
tetrahydro- 
2H-pyrazolo[3,4-
d]thiazole (Tugart 
et al., 2007) 
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5.6. Discussion 
The phyto-chemical test that was done for initial screening of the extract was 
complemented with detailed results obtained in GC/MS and LC/MS analysis.  
However, the MS results were more effective, allowing samples to be analysed with 
the minimum of quantities and analysis and covering as wide a range of classes of 
metabolite as possible in a short period. 
Phytochemical screening of indigenous plants is essential to evaluate their medical 
value and their potential use in the treatment of various diseases.  In the current 
study of A. laricinus extract, three secondary metabolites were found in the aqueous 
extract.  The extract showed the presence of ferulic acid, a phenolic acid derivative 
that has antioxidant activity and several therapeutic benefits in the treatment of 
cancer.  Ferulic acid is a plant constituent that arises from the metabolism of 
phenylalanine and tyrosine. It occurs primarily in seeds and leaves, both in its free 
form and covalently linked to lignin and other biopolymers.  Because of its phenolic 
nucleus and an extended side chain conjugation it readily forms a resonance 
stabilized phenoxy radical, which accounts for its potent antioxidant effect (Imaida et 
al., 1990; Srinivasan et al., 2007).  β-Sitosterol has a number of therapeutic and 
chemo-preventive uses in the medical field (Zak et al., 1990; Baskar et al., 2010). 
Indole-3-carbinol is used in prostate cancer (Garikapaty et al., 2005).  The 
phytoconstituents detected in the plant materials could be responsible for the 
cytotoxic activity, though their exact mode of action is poorly understood at present. 
The LC-MS chromatograms showed distinct profiles of the extracts.  This is 
important in investigating the health benefit claims in the traditional use of medicinal 
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plants.  It is therefore important to adapt isolation techniques to mimic the extraction 
methods used in traditional usage of medicinal plants.  Consistent with the chemical 
tests used for initial screening of different classes of metabolites, LC/MS results 
proved the presence of alkaloids in the aqueous extract, while no alkaloids could be 
found in the ethanol extract.  
It is important to note that the C39H38 NO4S in the aqueous extract was similar to a 
chemically synthesized derivative of the potential biologically active 4-thiazolidinones 
(Tugut et al., 2007).  Predominantly, the aqueous extract had small ring heterocycles 
containing nitrogen, sulfur and oxygen. Such molecules have been under 
investigation for a long time because of their important medicinal properties.  These 
types of molecules have been shown to have various important biological activities 
such as anti-microbial, anti-viral, diuretic, anti-histaminic, anti-cancer, anti-
convulsant, anti-inflammatory and analgesic properties (Vigorita et al., 2001; Kavitha 
et al., 2006; Kucukguzel et al., 2006). 
 
5.7. Conclusion 
 
This analysis of the aqueous and ethanol extracts of A. laricinus has helped to 
predict the compounds present in the respective solvents.  The identified molecules 
supported the evidence of important biological activities that had been observed in A. 
laricinus.  The use of chemical formulae in this study limited the identification of the 
plant extracts‟ metabolites to a narrow potential search field.  
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Summary 
 
This study reports on the anti-microbial, anti-oxidative stress, phytochemistry and 
free radical radical scavenging activity of Asparagus laricinus Burch (Asparagaceae) 
in order to explain the anti-cancer properties observed in extracts of this plant.  After 
demonstrating the anti-cancer properties of the A. laricinus, the study tested the 
biosafety of this plant by evaluating the antimutagenic and mutagenic water extract.  
The root extracts of Asparagus laricinus were qualitatively screened for antioxidant 
properties using 2, 2-diphenyl-1-picrylhydrazyl (DPPH), on silica gel GF254 TLC 
plates. Quantitative Radical scavenging activity using DPPH was also evaluated. 
The extracts were tested for the presence of alkaloids, saponins, tannins, terpenoids 
and steroids using standard phytochemical screening methods. Gas 
chromatography/mass spectrometry (GC/MS) was used to further confirm the 
phytoconstituents, in addition, LC/MS was used to profile the the phytoconstituents 
of the plant extract S.  Three spots that exhibited antioxidant activity were resolved 
on the TLC plates.  The results on the anti-bacterial activity of Asparagus laricinus 
showed that 50 μg/ml of the plant extract was the (MIC) for the gram-positive 
bacteria (Bacillus subtilis, Streptococcus pneumonia and Staphylococcus aureus).  
While 100 μg/ml was required for other gram-negative strains (Pseudomonas 
aeruginosa, Proteus vulgaris, Escherichia coli and Proteus vulgaris), Staphylococcus 
aureus was inhibited by 25 μg/ml of the plant extract.  Evaluation of the anti-oxidative 
stress activity of A. laricinus aqueous extract conclusively demonstrated the ability of 
the extract to protect Saccharomyces cerevisiae (BY4742) cells from oxidative stress 
when the cells were challenged with 10 Mm (H2O2) for 1.5 hours.  The results of this 
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study confirmed the anti-cancer and other biologically significant activities from the 
aqueous extract of A. laricinus.  The free radical scavenging activity of A. laricinus 
extract was comparable with that of Trolox and was dependent on the concentration 
of the extract.  This has shown that the effectiveness of the extract can be compared 
to that of commercial drugs.  The aqueous extract of A. laricinus contained alkaloids, 
saponins, tannins and terpenoids. However, the chemical tests on e ethanol extract 
produced negative results.  The phytoconstituents in the aqueous extract were 
confirmed through the use of GC/MS and indole-3-carbinol, α-sitosterol and ferulic 
acid were identified.  These identified compounds have known biological activities, 
and that is found to be consistent with the anticancer, anti-microbial and anti 
oxidative stress activities reported in the current study.  The phytochemicals present 
in the water extracts of A. laricinus and the in vitro anti-cancer properties indicate the 
potential use of this plant extract for development of novel drugs.  This study has 
also established a scientific basis for the continued use of A. laricinus in traditional 
medicine for the treatment of cancer and other ailments. 
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Abstract
several medicinal plants are traditionally used in the treatment of a variety of ailments including cancer in the rural areas of south 
Africa and our neighbouring countries where herbal medicine is one of the main components of the healthcare system. many of 
these herbs, including Asparagus laricinus, have not been scientifically assessed for efficacy or safety. the study on which this article 
is based evaluated the antimutagenic and mutagenic water extract of Asparagus laricinus roots used in the treatment of cancer. the 
Ames test recommended for mutagenicity screening was employed. the mutagenic activity was evaluated in salmonella typhimu-
rium strains tA97, tA98, tA100 and tA102. the mutagenicity tests of aqueous extracts were negative throughout (1:10, 1:25, 1:50. 
1:100, and 1:200). the highest antimutagenic effect in the order of 49% was observed using tA 98 (5µg daunomycin/plate), a strong 
mutagen. these results indicate the potential for use of this plant against cancer and oxidative stress-related diseases.
Keywords
medicinal plants, Asparagus laricinus, Ames test, antimutagenicity
INTRODUCTION
one of the most prominent diseases in humans today is can-
cer. it is projected that deaths from cancer are continuing to 
escalate, with an estimate of nine million deaths from cancer 
in the year 2015 and 11.4 million deaths by 2030[1]. gener-
ally, cancer begins after a mutational episode in a single cell 
and then it progressively transforms to malignancy in multiple 
stages through sequential acquisition of additional mutations[2]. 
in view of the fact that these initial events are the underlying 
causes of the whole progression of carcinogenesis, their inhi-
bition would therefore be an efficient preventive measure[3]. 
currently, there is marked scientific and commercial interest in 
the continuing discovery of new anti-cancer agents from natural 
product sources[4]. more than 50% of drugs used in clinical tri-
als for anti-cancer activity were isolated from natural sources or 
are related to them[5,6]. hence, the search for natural products to 
be used in cancer therapy represents an area of great interest in 
which the plant kingdom is the most important source, provid-
ing many anti-tumour agents with novel structures and unique 
mechanisms of action[7].
present chemotherapy cancer treatments have proved to be in-
effective as a result of their toxicity and cells developing resist-
ance[8]. many conventional drugs also induce genetic damage 
that itself can be carcinogenic. A segment of the research com-
munity is thus focusing on identifying novel chemotherapeutic 
agents in plants that do not induce the destructive effects of 
conventional cytotoxic therapeutic agents.
several medicinal plants are traditionally used in the treatment 
of a variety of ailments, including cancer in many communi-
ties in south Africa and neighbouring countries. since ancient 
times, herbal medicine has always been one of the main 
components of the healthcare system. in this study Asparagus 
laricinus belonging to Asparagaceae family was investigated. 
this is a monogeneric family, which was previously included 
within the Liliaceae family[9]. the genus Asparagus comprises 
approximately 100 species and consists of herbs, shrubs and 
vines. many of these herbs, including Asparagus laricinus, have 
not yet been scientifically assessed for their efficacy or safety to 
tissue or organs of recipients. thus, investigation of tradition-
ally used medicinal plants is valuable as a source of potential 
chemotherapeutic agents and also to assess the safety for the 
continuous use of medicinal plants. As a result, most studies are 
being directed at popular medicine, with the aim of identifying 
natural products which exhibit therapeutic properties[10,11]. 
the Ames test[12] was used in this study as it is widely used in the 
determination of possible gene mutations caused by extracts. 
A positive response in any single bacterial strain either with or 
without metabolic activation is sufficient to designate a sub-
stance as a mutagen[13]. the study being reported here evaluated 
the mutagenic and antimutagenic activity of the water extract 
of Asparagus laricinus roots which are known to be used in the 
treatment of cancer.
MATERIALS AND METHODS
Plant	material
the plant material (Asparagus laricinus) was authenticated by 
scientists at the national botanical gardens in pretoria, south 
Africa. the collected root materials were dried at room tem-
perature and pulverised by a mechanical mill and weighed. it 
was then stored in a cool place until analysis. plant material (10 
g of the dried roots) was weighed, pulverised and soaked in a 
volume of 500 ml of purified water for 72 hours with occasional 
stirring. the extracts were filtered and the solvent was removed 
completely by employing a rotatory evaporator.
The	Ames	test
the Ames test is a well-known bacterial mutagenicity test[11,14]. 
in this test, reverse his−→his+ mutations are visualised by plat-
ing salmonella typhimurium bacteria in a histidine-poor growth 
medium. in this medium only, his+ mutants are able to form vis-
ible colonies. different bacterial strains are available to identify 
different types of mutations. We used the strains tA97, tA98, 
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tA100 and tA102. the strains tA98 and tA100 are actually 
those that are most often used as they detect the great major-
ity of mutagens. strain tA98 gives an indication of frame-shift 
mutations, while a positive response from strain tA100 indi-
cates base-pair substitution. for a substance to be considered 
genotoxic in the Ames test, the number of revertant colonies on 
the plates containing the test compounds should be more than 
twice the number of colonies produced on the solvent control 
plates (i.e. a ratio above 2.0). in addition, a dose-response 
should be evident for the various concentrations of the mutagen 
tested. toxicity can be checked by investigation of the back-
ground layer of bacteria. 
Antimutagenicity was expressed as percentage inhibition of 
mutagenicity according to the following formula given for the 
Ames test[15]:
% inhibition = [1 – t/m] x 100
where T is the number of revertants per plate in the presence of 
mutagen and the test sample and M is the number of revertants 
per plate in the positive control (mutagen alone). the same for-
mula was also adopted for other tests. An extract was considered 
to have no or only weak antimutagenic properties when the per-
centage inhibition of mutagenicity (e.g. revertants in the Ames 
assay) was less than 25%. When the percentage inhibition was 
between 25% and 40% it was considered that the extract had 
a moderate antimutagenic effect and it was concluded that an 
extract had a strong antimutagenic effect when the percentage 
inhibition was higher than 40%. dimethyl sulfoxide (dmso) 
was used as a negative control, while daunomycin (10µl/plate) 
was used as a positive control. All experiments were performed 
in triplicate. the metabolic activation (s9) was donated by the 
mrc Liver research centre, tygerberg, cape town.
Determination	of	total	phenolic	content
total phenolic content in Asparagus laricinus extract was deter-
mined employing folin-ciocalteu reagent[16], with minor adap-
tations. gallic acid was used as a standard phenolic compound. 
in a test tube, 0.5ml of plant extract or standard solution was 
added, followed by 35 ml of h2o and 2.5ml of folin-ciocalteu 
reagent. the content was mixed thoroughly. After 8 minutes, 
7.5ml naco3 (10% w/v) was added. the mixture was allowed 
to stand in the dark for 1 hour. Absorbance was measured at 
760nm using a spectrophotometer. the concentration of total 
phenolic compounds in plant extracts was determined from the 
gallic acid standard curve. 
RESULTS AND DISCUSSION
the standard plate incorporation methods for the Ames test us-
ing salmonella typhimurium standard tester strains tA97, tA98, 
tA100 and tA102 exposed to five dilutions with and without 
s9 metabolic activation of the herbal mixtures were performed. 
the Ames test without s9 metabolic activation can only detect 
direct mutagens while with s9 metabolic activation allows the 
detection of indirect mutagens, often caused by conjugation 
reactions of metabolic oxidation systems. table 1 and 2 present 
the spontaneous reversion response of the salmonella typh-
imurium tester strain to the different dilutions of the Asparagus 
laricinus extract. the results revealed that Asparagus laricinus 
extracts were non-mutagenic towards the salmonella typhimu-
rium strains tA97, tA98, tA100 and tA102 for the assay without 
metabolic activation. the average his+ revertants observed for 
all the tester strains caused by the extracts at all the concentra-
tions without metabolic activation did not satisfy the criteria for 
mutagenicity. there was no notable dose-dependent increase in 
the number of revertants and the numbers of revertants were all 
either not equal to or greater than twice that of the negative con-
trol[17]. there was also no decrease in the number of revertant 
colonies to levels far below the negative control (spontaneous 
reversion) which could also be classified as toxic. the extract 
had moderate (28%-34%) inhibitory effects using salmonella 
typhimurium tA100 strain. the upper limit was observed begin-
ning with mutagen and followed by the anti-mutagen (extract). 
the lower limit was observed beginning with an anti-mutagen 
followed by a mutagen. When both mutagen and anti-mutagen 
were operative on commencement of a possible disease, 31% 
inhibition was observed. similarly, using salmonella typhimu-
rium tA102 strain, the extract showed a low to moderate in-
hibitory effect (24%-38%). the lower limit represented mutagen 
followed by anti-mutagen and the upper limit was observed 
when both mutagen and anti-mutagen were operative on com-
mencement of a possible disease. however, using salmonella 
Table 2: Mutagenic activities of Asparagus laricinus extract with metabolic 
activation (+S9).
S. typhymurium strain Dilution Mean +/- SD
TA 97 50X 154 +/-7
TA 97 100X 154+/-10
TA 97 200X 163+/-12
TA 97 control (+) n/a 351
TA 97 control (-) n/a 351
TA 98 50X 40+/-6
TA 98 100X 32+/-8
TA 98 200X 45+/-6
TA 98 control (+) n/a 830
TA 98 control (-) n/a 53
TA 100 50X 123+/-4
TA 100 100X 131+/-3
TA 100 200X 132+/-8
TA 100 Control (+) n/a 1395
TA 100 Control (-) n/a 183
TA 102 50X 451+/-47
TA 102 100X 406+/-51
TA 102 200X 405+/-50
TA 102 control (+) n/a 1395
TA 102 control (-) n/a 391
SD is standard deviation of three repeats in the experiment
Table 1: Summary of mutagenic/anti-mutagenic properties of Asparagus laricinus extract.
Mutagen/anti-mutagen Mutagen + anti-mutagen
TA 97 TA 98 TA 100 TA 102 TA 97 TA 98 TA 100 TA 102
Dilutions Percentage inhibition Percentage inhibition
50X 21 49 28.6 22.7 20.2 23.4 31.6 37.5
100X 10.4 35.1 12.1 23.5 14.5 19.5 28.4 24
200X 9.1 21.9 19 21.5 7.6 17.1 15.5 21
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typhimurium tA97 strain, the extract had a low inhibitory effect 
(20%-22%). the degree of inhibition was not affected by the 
mode of interaction of the mutagen and anti-mutagen. finally, 
the inhibitory effect was observed over a wide spectrum using 
salmonella typhimurium tA98 strain (23%-49%). the upper 
limit was observed beginning with a mutagen and followed by 
the anti-mutagen. the lower limit was observed when there was 
simultaneous interaction between a mutagen and the extract. 
When both mutagen and anti-mutagen were operative on com-
mencement of a possible disease, 35% inhibition was observed.
the Ames test with metabolic activation was carried out by ad-
dition of the s9 mix so as to detect an indirect mutagenic effect 
caused by metabolites of the test Asparagus laricinus extract. 
the s9 fraction contains a mixture of xenobiotic metabolising 
enzymes, such as the cytochrome p450s and sulfotransferase. 
Asparagus laricinus extract showed an indirect mutagenic effect 
toward the tester strain tA102 after metabolic activation but not 
in the other tester strains (tA97, tA98, and tA100).
the rationale for screening for antimutagenicity was that anti-
mutagenic compounds can possibly also be anticarcinogens. 
these results have stimulated us to carry out ongoing work to 
determine the active ingredients since these may prove valu-
able lead compounds in the light of their antimutagenic ability. 
no data relative to cytotoxic components of Asparagus larici-
nus had been reported and further phytochemical work on the 
isolation and identification of active structures of this plant is 
presently in progress.
As assessed by the folin-ciocalteu method, the total phenolic 
content in the extracts are presented as gallic acid equivalents 
(gAe) with reference to the gallic acid standard curve which 
was plotted using the average absorbance values of two inde-
pendent sets of data against concentrations of gallic acid in 
g/l. the Asparagus laricinus aqueous extract contained 4.2g/l 
gAe. polyphenols are the most abundant dietary antioxidants 
and research on their role in the prevention of degenerative 
diseases and cancer has developed quickly over these last few 
years. With a transgenic adenocarcinoma of the mouse prostate 
model of prostate carcinogenesis (trAmp), it was recently dem-
onstrated that oral consumption of 10g/l green tea polyphenols 
decreased tumour incidence by 65%[18], the latter polyphenol 
preparation was enriched with epigallocatechin-3-gallate 
(62%), epicatechin-3-gallate (24%), epigallocatechin (5%), epi-
catechin (6%), and caffeine (‘1%). it is worth mentioning that 
the ratio of individual constituent polyphenols may vary from 
plant to plant. evaluation of the Asparagus laricinus aqueous 
extract on human melanoma cell lines is presently in progress. 
many researchers have inferred the antimutagenic activity of 
plant extract to the antioxidant activities of the polyphenols. 
however, there is now a paradigm shift. owing to a study that 
showed Asparagus racemosus extracts induced excessive pro-
duction of tnf-alpha as compared to controls[19], similar reports 
are increasing. naturally, white blood cells produce tnf-alpha 
protein to stimulate and activate the immune system in response 
to infection or cancer. the current state of knowledge suggests 
that the mode of action of many plant extracts is between scav-
enging for free radicals and modulation of the immune system. 
the evidence obtained in studies of a tea polyphenol i.e. (-)-epi-
gallocatechin gallate [(-)-egcg], indicate that plant polyphe-
nols target many enzymes directly associated with cancer (e.g. 
proteosome, telomerase, growth factors, mApKs, etc.)[20,21,22,23]
CONCLUSION
Asparagus laricinus polyphenol extract exhibited a dose de-
pendent antimutagenic ability. the plant extract showed no mu-
tagenic effect on all tested strains. however, mutagenic activity 
was observed with metabolic activation for the tA 102 tester 
strain only, to the exclusion of (tA97, tA98, and tA100). these 
results indicate the potential for use of this plant against cancer 
and oxidative stress-related diseases. Although these results 
support the use of Asparagus laricinus for treatment of cancer, 
further investigation is required, for this promising plant.
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